BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy15291
(295 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 138 bits (348), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 69/185 (37%), Positives = 108/185 (58%), Gaps = 7/185 (3%)
Query: 108 AVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICM 167
AV G + ++ L + + ++ + +++++ Y+ NDIA++ LE + Y +I PIC+
Sbjct: 55 AVLGLH-MASNLTSPQIETRLIDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQPICL 113
Query: 168 PKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINS 226
P+++ F GR+ +++GWG L Y G VLQE VP++ N CQ+ I +
Sbjct: 114 PEENQVFPPGRICSIAGWGALIYQGSTADVLQEADVPLLSNEKCQQQMPE----YNITEN 169
Query: 227 FLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKP 286
+CAGY G DSC+GDSGGPLM + E+ W+LAG S G +CA P PGVY R +
Sbjct: 170 MVCAGYEAGGVDSCQGDSGGPLMCQ-ENNRWLLAGVTSFGYQCALPNRPGVYARVPRFTE 228
Query: 287 WLQTI 291
W+Q+
Sbjct: 229 WIQSF 233
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 132 bits (331), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 65/189 (34%), Positives = 107/189 (56%), Gaps = 7/189 (3%)
Query: 104 ANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIV 163
+ A+ G + + L + +++ + + ++++ Y+ +NDIA++ LE + Y +I
Sbjct: 51 SKWTAILGLH-MKSNLTSPQTVPRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQ 109
Query: 164 PICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKT 222
PI +P+++ F GR +++GWG + Y G +LQE VP++ N CQ+
Sbjct: 110 PISLPEENQVFPPGRNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQMPE----YN 165
Query: 223 IINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTT 282
I + +CAGY G DSC+GDSGGPLM + E+ W LAG S G +CA P PGVY R +
Sbjct: 166 ITENMICAGYEEGGIDSCQGDSGGPLMCQ-ENNRWFLAGVTSFGYECALPNRPGVYARVS 224
Query: 283 YYKPWLQTI 291
+ W+Q+
Sbjct: 225 RFTEWIQSF 233
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 129 bits (324), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 70/186 (37%), Positives = 107/186 (57%), Gaps = 8/186 (4%)
Query: 104 ANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIV 163
+ L V GE D+S +++ I+ V ++I+H +D +NDI+LL+L + ++ ++
Sbjct: 56 SGLQIVAGELDMSVNEGSEQIIT--VSKIILHENFDYNLLDNDISLLKLSGSLTFNDNVA 113
Query: 164 PICMPKDDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTI 223
PI +P+ TG V V+GWG GG P VLQ+V VP++ + C+ + A I
Sbjct: 114 PIALPEQGHTATGDV-IVTGWGTTSEGGNTPDVLQKVTVPLVSDEDCRADYG----ADEI 168
Query: 224 INSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTY 283
++S +CAG G +DSC+GDSGGPL + G LAG VS G CA P PGVY +Y
Sbjct: 169 LDSMICAGVPEGGKDSCQGDSGGPLA-ASDTGSTYLAGIVSWGYGCARPGYPGVYTEVSY 227
Query: 284 YKPWLQ 289
+ W++
Sbjct: 228 HVDWIK 233
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 127 bits (318), Expect = 9e-30, Method: Compositional matrix adjust.
Identities = 66/169 (39%), Positives = 103/169 (60%), Gaps = 7/169 (4%)
Query: 129 VRRVIVHRQYDAATFENDIALLE-LETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
V+ +H QYD TFEND+AL+E LE+P+ ++ ++PIC+P+ G + VSGWG+
Sbjct: 242 VKHTTLHPQYDPNTFENDVALVELLESPV-LNAFVMPICLPEGPQQ-EGAMVIVSGWGK- 298
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
++ P L E+++P+++++ CQ+ + A K + +CAG G +D+C GDSGGP
Sbjct: 299 QFLQRFPETLMEIEIPIVDHSTCQKAY--APLKKKVTRDMICAGEKEGGKDACAGDSGGP 356
Query: 248 LM-IEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTITGVQ 295
++ + RE G W L GTVS G C GVY + K W+Q +TGV+
Sbjct: 357 MVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYIHHNKDWIQRVTGVR 405
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 126 bits (317), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 77/201 (38%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 97 LSKIGFLANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPI 156
KI NL+AV GE+D+S E + S+ V +VI+ Y T +DIALL L P+
Sbjct: 43 FDKIKNWRNLIAVLGEHDLS-EHDGDEQ-SRRVAQVIIPSTYVPGTTNHDIALLRLHQPV 100
Query: 157 AYDSHIVPICMPKDDDDFTGRV------ATVSGWGRLKYGGGVPSVLQEVQVPVIENNVC 210
H+VP+C+P + F+ R + VSGWG+L G VLQ + VP + C
Sbjct: 101 VLTDHVVPLCLP--ERTFSERTLAFVRFSLVSGWGQLLDRGATALVLQVLNVPRLMTQDC 158
Query: 211 QEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCA 270
+ + G + I CAGY++G +DSC+GDSGGP G W L G VS G CA
Sbjct: 159 LQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYR-GTWYLTGIVSWGQGCA 217
Query: 271 APYLPGVYMRTTYYKPWLQTI 291
GVY R + Y WLQ +
Sbjct: 218 TVGHFGVYTRVSQYIEWLQKL 238
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 126 bits (316), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 66/169 (39%), Positives = 103/169 (60%), Gaps = 7/169 (4%)
Query: 129 VRRVIVHRQYDAATFENDIALLE-LETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
V+ +H QYD TFEND+AL+E LE+P+ ++ ++PIC+P+ G + VSGWG+
Sbjct: 87 VKHTTLHPQYDPNTFENDVALVELLESPV-LNAFVMPICLPEGPQQ-EGAMVIVSGWGK- 143
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
++ P L E+++P+++++ CQ+ + A K + +CAG G +D+C GDSGGP
Sbjct: 144 QFLQRFPETLMEIEIPIVDHSTCQKAY--APLKKKVTRDMICAGEKEGGKDACAGDSGGP 201
Query: 248 LM-IEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTITGVQ 295
++ + RE G W L GTVS G C GVY + K W+Q +TGV+
Sbjct: 202 MVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYIHHNKDWIQRVTGVR 250
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 125 bits (315), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 101/189 (53%), Gaps = 7/189 (3%)
Query: 107 VAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPIC 166
A G +D S + A + ++R+I H ++ TF+ DIALLELE P Y S + PIC
Sbjct: 59 TAFLGLHDQS-QRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPIC 117
Query: 167 MPKDDDDF-TGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN 225
+P F G+ V+GWG +YGG +LQ+ ++ VI+ C+ + + I
Sbjct: 118 LPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCENLL-----PQQITP 172
Query: 226 SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYK 285
+C G+ +G DSC+GDSGGPL DG AG VS G CA PGVY R ++
Sbjct: 173 RMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFR 232
Query: 286 PWLQTITGV 294
W++ TGV
Sbjct: 233 DWIKENTGV 241
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 125 bits (313), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 100/189 (52%), Gaps = 7/189 (3%)
Query: 107 VAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPIC 166
A G +D S + A + ++R+I H ++ TF+ DIALLELE P Y S + PIC
Sbjct: 59 TAFLGLHDQS-QRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPIC 117
Query: 167 MPKDDDDF-TGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN 225
+P F G+ V+GWG +YGG +LQ+ ++ VI C+ + + I
Sbjct: 118 LPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLL-----PQQITP 172
Query: 226 SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYK 285
+C G+ +G DSC+GDSGGPL DG AG VS G CA PGVY R ++
Sbjct: 173 RMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFR 232
Query: 286 PWLQTITGV 294
W++ TGV
Sbjct: 233 DWIKENTGV 241
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 122 bits (305), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 68/168 (40%), Positives = 97/168 (57%), Gaps = 10/168 (5%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVATVSGWGRL 187
V R+IVH Q+ A DIALLELE P+ SH+ + +P + F G V+GWG +
Sbjct: 74 VSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDV 133
Query: 188 KYGGGVPSV--LQEVQVPVIENNVCQEMFQ----TAGHAKTIINSFLCAGYANGQRDSCE 241
+P L++V+VP++EN++C + T + + + LCAG N +RDSC+
Sbjct: 134 DNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--NTRRDSCQ 191
Query: 242 GDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
GDSGGPL+ + +G W+ AG VS G CA P PG+Y R TYY W+
Sbjct: 192 GDSGGPLVC-KVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIH 238
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 122 bits (305), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 68/168 (40%), Positives = 97/168 (57%), Gaps = 10/168 (5%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVATVSGWGRL 187
V R+IVH Q+ A DIALLELE P+ SH+ + +P + F G V+GWG +
Sbjct: 74 VSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDV 133
Query: 188 KYGGGVPSV--LQEVQVPVIENNVCQEMFQ----TAGHAKTIINSFLCAGYANGQRDSCE 241
+P L++V+VP++EN++C + T + + + LCAG N +RDSC+
Sbjct: 134 DNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--NTRRDSCQ 191
Query: 242 GDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
GDSGGPL+ + +G W+ AG VS G CA P PG+Y R TYY W+
Sbjct: 192 GDSGGPLVC-KVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIH 238
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 122 bits (305), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 68/168 (40%), Positives = 97/168 (57%), Gaps = 10/168 (5%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVATVSGWGRL 187
V R+IVH Q+ A DIALLELE P+ SH+ + +P + F G V+GWG +
Sbjct: 74 VSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDV 133
Query: 188 KYGGGVPSV--LQEVQVPVIENNVCQEMFQ----TAGHAKTIINSFLCAGYANGQRDSCE 241
+P L++V+VP++EN++C + T + + + LCAG N +RDSC+
Sbjct: 134 DNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--NTRRDSCQ 191
Query: 242 GDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
GDSGGPL+ + +G W+ AG VS G CA P PG+Y R TYY W+
Sbjct: 192 GDSGGPLVC-KVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIH 238
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 122 bits (305), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 75/201 (37%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 97 LSKIGFLANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPI 156
KI NL+AV GE+D+S E + S+ V +VI+ Y T +DIALL L P+
Sbjct: 43 FDKIKNWRNLIAVLGEHDLS-EHDGDEQ-SRRVAQVIIPSTYVPGTTNHDIALLRLHQPV 100
Query: 157 AYDSHIVPICMPKDDDDFTGRV------ATVSGWGRLKYGGGVPSVLQEVQVPVIENNVC 210
H+VP+C+P + F+ R + VSGWG+L G L + VP + C
Sbjct: 101 VLTDHVVPLCLP--ERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDC 158
Query: 211 QEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCA 270
+ + G + I CAGY++G +DSC+GDSGGP G W L G VS G CA
Sbjct: 159 LQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYR-GTWYLTGIVSWGQGCA 217
Query: 271 APYLPGVYMRTTYYKPWLQTI 291
GVY R + Y WLQ +
Sbjct: 218 TVGHFGVYTRVSQYIEWLQKL 238
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 121 bits (304), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 99/189 (52%), Gaps = 7/189 (3%)
Query: 107 VAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPIC 166
A G +D S + A + ++R+I H ++ TF+ DIALLELE P Y S + PI
Sbjct: 59 TAFLGLHDQS-QRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPIS 117
Query: 167 MPKDDDDF-TGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN 225
+P F G+ V+GWG +YGG +LQ+ ++ VI C+ + + I
Sbjct: 118 LPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLL-----PQQITP 172
Query: 226 SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYK 285
+C G+ +G DSC+GDSGGPL DG AG VS G CA PGVY R ++
Sbjct: 173 RMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFR 232
Query: 286 PWLQTITGV 294
W++ TGV
Sbjct: 233 DWIKENTGV 241
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 121 bits (303), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 69/188 (36%), Positives = 105/188 (55%), Gaps = 11/188 (5%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP 168
V GE+D S +++ +V + V+ YD AT END+++++ I +D ++ PIC P
Sbjct: 56 VVGEHDSSAASTVRQT--HDVDSIFVNENYDPATLENDVSVIKTAVAITFDINVGPICAP 113
Query: 169 KDDDDFTGRVATVSGWGRLKYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSF 227
+D+ R + SGWG + GG P+VL+ V + + N C ++ + TI +
Sbjct: 114 DPANDYVYRKSQCSGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTS----DTIYDDM 169
Query: 228 LCAGYANG--QRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYK 285
+CA G RDSC+GDSGGPL ++ G + L G VS GI CA+ Y PGVY R ++
Sbjct: 170 ICATDNTGMTDRDSCQGDSGGPLSVKDGSGIFSLVGIVSWGIGCASGY-PGVYSRVGFHA 228
Query: 286 PWL-QTIT 292
W+ TIT
Sbjct: 229 GWITDTIT 236
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 120 bits (301), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 64/171 (37%), Positives = 96/171 (56%), Gaps = 4/171 (2%)
Query: 125 ISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVATVSG 183
+ + +RR+IVH +Y + + DI+L EL +P+ Y + + +C+P +F G V V+G
Sbjct: 65 MKRGLRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRVCLPDASYEFQPGDVMFVTG 124
Query: 184 WGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGD 243
+G LK G + L++ QV +I+ C E + I LCAG G+ D+C+GD
Sbjct: 125 FGALKNDGYSQNHLRQAQVTLIDATTCNE---PQAYNDAITPRMLCAGSLEGKTDACQGD 181
Query: 244 SGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTITGV 294
SGGPL+ W LAG VS G +CA P PGVY R T + W+ + TG+
Sbjct: 182 SGGPLVSSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWITSKTGI 232
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 118 bits (296), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 84/234 (35%), Positives = 121/234 (51%), Gaps = 32/234 (13%)
Query: 79 QFPQQDSMMTNFDMFT----INLSKIGFLANLV-------AVFGEYDI--SGELEAKRSI 125
QFP Q + D F +N I A+ V V GE++I + E KR
Sbjct: 11 QFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKR-- 68
Query: 126 SKNVRRVIVHRQYDAA--TFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRV----- 178
NV R+I H Y+AA T+ +DIALLEL+ P+ +S++ PIC+ D ++T
Sbjct: 69 --NVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIA--DKEYTNIFLKFGS 124
Query: 179 ATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRD 238
VSGWGR+ + G VLQ ++VP+++ C + TI N+ CAG+ G RD
Sbjct: 125 GYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKF-----TITNNMFCAGFHEGGRD 179
Query: 239 SCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
SC+GDSGGP + E E G L G +S G +CA G+Y + + Y W++ T
Sbjct: 180 SCQGDSGGPHVTEVE-GTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKT 232
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 118 bits (295), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 68/168 (40%), Positives = 95/168 (56%), Gaps = 10/168 (5%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVATVSGWGRL 187
V R+IVH Q+ DIALLELE P+ S + + +P + F G V+GWG +
Sbjct: 74 VSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPASETFPPGMPCWVTGWGDV 133
Query: 188 KYGGGVPSV--LQEVQVPVIENNVCQEMFQ----TAGHAKTIINSFLCAGYANGQRDSCE 241
+P L++V+VP++EN++C + T + I + LCAG N QRDSC+
Sbjct: 134 DNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--NSQRDSCQ 191
Query: 242 GDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
GDSGGPL+ + +G W+ AG VS G CA P PG+Y R TYY W+
Sbjct: 192 GDSGGPLVC-KVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIH 238
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 117 bits (294), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 68/168 (40%), Positives = 95/168 (56%), Gaps = 10/168 (5%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVATVSGWGRL 187
V R+IVH Q+ DIALLELE P+ S + + +P + F G V+GWG +
Sbjct: 74 VSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPASETFPPGMPCWVTGWGDV 133
Query: 188 KYGGGVPSV--LQEVQVPVIENNVCQEMFQ----TAGHAKTIINSFLCAGYANGQRDSCE 241
+P L++V+VP++EN++C + T + I + LCAG N QRDSC+
Sbjct: 134 DNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--NSQRDSCK 191
Query: 242 GDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
GDSGGPL+ + +G W+ AG VS G CA P PG+Y R TYY W+
Sbjct: 192 GDSGGPLVC-KVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIH 238
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 117 bits (294), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 83/234 (35%), Positives = 121/234 (51%), Gaps = 32/234 (13%)
Query: 79 QFPQQDSMMTNFDMF----TINLSKIGFLANLV-------AVFGEYDI--SGELEAKRSI 125
QFP Q + D F +N I A+ V V GE++I + E KR
Sbjct: 11 QFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKR-- 68
Query: 126 SKNVRRVIVHRQYDAA--TFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRV----- 178
NV R+I H ++AA T+ +DIALLEL+ P+ +S++ PIC+ D ++T
Sbjct: 69 --NVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIA--DKEYTNIFLKFGS 124
Query: 179 ATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRD 238
VSGWGR+ + G VLQ ++VP+++ C + TI N+ CAG+ G RD
Sbjct: 125 GYVSGWGRVFHKGRAALVLQYLRVPLVDRATCLRSTKF-----TITNNMFCAGFHEGGRD 179
Query: 239 SCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
SC+GDSGGP + E E G L G +S G +CA G+Y + + Y W++ T
Sbjct: 180 SCQGDSGGPHVTEVE-GTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKT 232
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 117 bits (293), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 83/234 (35%), Positives = 121/234 (51%), Gaps = 32/234 (13%)
Query: 79 QFPQQDSMMTNFDMFT----INLSKIGFLANLV-------AVFGEYDI--SGELEAKRSI 125
QFP Q + D F +N I A+ V V GE++I + E KR
Sbjct: 11 QFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKR-- 68
Query: 126 SKNVRRVIVHRQYDAA--TFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRV----- 178
NV R+I H ++AA T+ +DIALLEL+ P+ +S++ PIC+ D ++T
Sbjct: 69 --NVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIA--DKEYTNIFLKFGS 124
Query: 179 ATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRD 238
VSGWGR+ + G VLQ ++VP+++ C + TI N+ CAG+ G RD
Sbjct: 125 GYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKF-----TITNNMFCAGFHEGGRD 179
Query: 239 SCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
SC+GDSGGP + E E G L G +S G +CA G+Y + + Y W++ T
Sbjct: 180 SCQGDSGGPHVTEVE-GTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKT 232
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 116 bits (291), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 83/234 (35%), Positives = 120/234 (51%), Gaps = 32/234 (13%)
Query: 79 QFPQQDSMMTNFDMFT----INLSKIGFLANLV-------AVFGEYDI--SGELEAKRSI 125
QFP Q + D F +N I A+ V V GE++I + E KR
Sbjct: 11 QFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKR-- 68
Query: 126 SKNVRRVIVHRQYDAA--TFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRV----- 178
NV R+I H Y+AA + +DIALLEL+ P+ +S++ PIC+ D ++T
Sbjct: 69 --NVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIA--DKEYTNIFLKFGS 124
Query: 179 ATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRD 238
VSGWGR+ + G VLQ ++VP+++ C + TI N+ CAG+ G RD
Sbjct: 125 GYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKF-----TIYNNMFCAGFHEGGRD 179
Query: 239 SCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
SC+GDSGGP + E E G L G +S G +CA G+Y + + Y W++ T
Sbjct: 180 SCQGDSGGPHVTEVE-GTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKT 232
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 115 bits (288), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 58/161 (36%), Positives = 89/161 (55%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRV-ATVSGWGRL 187
++ +I+H+ Y + +DIAL++L+ P+ Y PI +P D T V+GWG
Sbjct: 76 IKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLPSKGDTSTIYTNCWVTGWGFS 135
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
K G + ++LQ+V +P++ N CQ+ +Q I +CAGY G +D+C+GDSGGP
Sbjct: 136 KEKGEIQNILQKVNIPLVTNEECQKRYQDY----KITQRMVCAGYKEGGKDACKGDSGGP 191
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L+ + +G W L G S G CA PGVY + Y W+
Sbjct: 192 LVC-KHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI 231
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 115 bits (288), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 67/168 (39%), Positives = 94/168 (55%), Gaps = 10/168 (5%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVATVSGWGRL 187
V R+IVH Q+ DIALLELE P+ S + + +P + F G V+GWG +
Sbjct: 74 VSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPASETFPPGMPCWVTGWGDV 133
Query: 188 KYGGGVPSV--LQEVQVPVIENNVCQEMFQ----TAGHAKTIINSFLCAGYANGQRDSCE 241
+P L++V+VP++EN++C + T + I + LCAG N QRDSC+
Sbjct: 134 DNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--NSQRDSCK 191
Query: 242 GDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
GDSGGPL+ + +G W+ AG VS CA P PG+Y R TYY W+
Sbjct: 192 GDSGGPLVC-KVNGTWLQAGVVSWDEGCAQPNRPGIYTRVTYYLDWIH 238
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 115 bits (287), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 82/234 (35%), Positives = 120/234 (51%), Gaps = 32/234 (13%)
Query: 79 QFPQQDSMMTNFDMFT----INLSKIGFLANLV-------AVFGEYDI--SGELEAKRSI 125
QFP Q + D F +N I A+ V V GE++I + E KR
Sbjct: 11 QFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKR-- 68
Query: 126 SKNVRRVIVHRQYDAA--TFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRV----- 178
NV R+I H Y+AA + +DIALLEL+ P+ +S++ PIC+ D ++T
Sbjct: 69 --NVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIA--DKEYTNIFLKFGS 124
Query: 179 ATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRD 238
VSGWGR+ + G VLQ ++VP+++ C + TI N+ CAG+ G RD
Sbjct: 125 GYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKF-----TIYNNMFCAGFHEGGRD 179
Query: 239 SCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
SC+GD+GGP + E E G L G +S G +CA G+Y + + Y W++ T
Sbjct: 180 SCQGDAGGPHVTEVE-GTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKT 232
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 115 bits (287), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 58/161 (36%), Positives = 89/161 (55%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRV-ATVSGWGRL 187
++ +I+H+ Y + +DIAL++L+ P+ Y PI +P D T V+GWG
Sbjct: 76 IKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISLPSKGDTSTIYTNCWVTGWGFS 135
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
K G + ++LQ+V +P++ N CQ+ +Q I +CAGY G +D+C+GDSGGP
Sbjct: 136 KEKGEIQNILQKVNIPLVTNEECQKRYQDY----KITQRMVCAGYKEGGKDACKGDSGGP 191
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L+ + +G W L G S G CA PGVY + Y W+
Sbjct: 192 LVC-KHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI 231
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 112 bits (281), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 93 FTINLSKIGFLANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLEL 152
+ + + G + V V GE+D E + + + +V + +Y++ T NDI LL+L
Sbjct: 36 WVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKL--KIAKVFKNSKYNSLTINNDITLLKL 93
Query: 153 ETPIAYDSHIVPICMPKDDDDF-TGRVATVSGWGRLKY-GGGVPSVLQEVQVPVIENNVC 210
T ++ + +C+P DDF G +GWG +Y P LQ+ +P++ N C
Sbjct: 94 STAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNC 153
Query: 211 QEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCA 270
++ + T I ++ +CAG A+G SC GDSGGPL+ +++G W L G VS G
Sbjct: 154 KKYWGTK-----IKDAMICAG-ASG-VSSCMGDSGGPLVC-KKNGAWTLVGIVSWGSSTC 205
Query: 271 APYLPGVYMRTTYYKPWLQ 289
+ PGVY R T W+Q
Sbjct: 206 STSTPGVYARVTALVNWVQ 224
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 112 bits (280), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 62/161 (38%), Positives = 88/161 (54%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP-KDDDDFTGRVATVSGWGRL 187
V+ +I+H QY A DIALL+LET + Y PIC+P K D + V+GWG
Sbjct: 463 VQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYR 522
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
K + + LQ+ ++P++ N CQ+ ++ GH I + +CAGY G +D+C+GDSGGP
Sbjct: 523 KLRDKIQNTLQKAKIPLVTNEECQKRYR--GHK--ITHKMICAGYREGGKDACKGDSGGP 578
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L + + W L G S G CA PGVY Y W+
Sbjct: 579 LSCKHNEV-WHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 618
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 112 bits (279), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 93 FTINLSKIGFLANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLEL 152
+ + + G + V V GE+D E + + + +V + +Y++ T NDI LL+L
Sbjct: 51 WVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKL--KIAKVFKNSKYNSLTINNDITLLKL 108
Query: 153 ETPIAYDSHIVPICMPKDDDDF-TGRVATVSGWGRLKY-GGGVPSVLQEVQVPVIENNVC 210
T ++ + +C+P DDF G +GWG +Y P LQ+ +P++ N C
Sbjct: 109 STAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNC 168
Query: 211 QEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCA 270
++ + T I ++ +CAG + SC GDSGGPL+ +++G W L G VS G
Sbjct: 169 KKYWGTK-----IKDAMICAGASG--VSSCMGDSGGPLVC-KKNGAWTLVGIVSWGSSTC 220
Query: 271 APYLPGVYMRTTYYKPWLQ 289
+ PGVY R T W+Q
Sbjct: 221 STSTPGVYARVTALVNWVQ 239
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 111 bits (278), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 62/161 (38%), Positives = 88/161 (54%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP-KDDDDFTGRVATVSGWGRL 187
V+ +I+H QY A DIALL+LET + Y PIC+P K D + V+GWG
Sbjct: 76 VQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYR 135
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
K + + LQ+ ++P++ N CQ+ ++ GH I + +CAGY G +D+C+GDSGGP
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYR--GHK--ITHKMICAGYREGGKDACKGDSGGP 191
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L + + W L G S G CA PGVY Y W+
Sbjct: 192 LSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 111 bits (278), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 62/161 (38%), Positives = 88/161 (54%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP-KDDDDFTGRVATVSGWGRL 187
V+ +I+H QY A DIALL+LET + Y PIC+P K D + V+GWG
Sbjct: 76 VQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRNVIYTDCWVTGWGYR 135
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
K + + LQ+ ++P++ N CQ+ ++ GH I + +CAGY G +D+C+GDSGGP
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYR--GHK--ITHKMICAGYREGGKDACKGDSGGP 191
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L + + W L G S G CA PGVY Y W+
Sbjct: 192 LSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 111 bits (278), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 62/161 (38%), Positives = 88/161 (54%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP-KDDDDFTGRVATVSGWGRL 187
V+ +I+H QY A DIALL+LET + Y PIC+P K D + V+GWG
Sbjct: 76 VQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRNVIYTDCWVTGWGYR 135
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
K + + LQ+ ++P++ N CQ+ ++ GH I + +CAGY G +D+C+GDSGGP
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYR--GHK--ITHKMICAGYREGGKDACKGDSGGP 191
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L + + W L G S G CA PGVY Y W+
Sbjct: 192 LSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 110 bits (276), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 61/171 (35%), Positives = 87/171 (50%), Gaps = 13/171 (7%)
Query: 128 NVRRVIVHRQY------DAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVAT 180
V+ V+ H Y ++ NDIAL+ L +P+ +I P+C+P G++ T
Sbjct: 188 GVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICT 247
Query: 181 VSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSC 240
V+GWG +Y G VLQE +VP+I N+VC + I CAGY G D+C
Sbjct: 248 VTGWGNTQYYGQQAGVLQEARVPIISNDVCN---GADFYGNQIKPKMFCAGYPEGGIDAC 304
Query: 241 EGDSGGPLMIE---REDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
+GDSGGP + E W L G VS G CA PGVY + + ++ W+
Sbjct: 305 QGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWI 355
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 110 bits (276), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 61/171 (35%), Positives = 87/171 (50%), Gaps = 13/171 (7%)
Query: 128 NVRRVIVHRQY------DAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVAT 180
V+ V+ H Y ++ NDIAL+ L +P+ +I P+C+P G++ T
Sbjct: 188 GVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICT 247
Query: 181 VSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSC 240
V+GWG +Y G VLQE +VP+I N+VC + I CAGY G D+C
Sbjct: 248 VTGWGNTQYYGQQAGVLQEARVPIISNDVCN---GADFYGNQIKPKMFCAGYPEGGIDAC 304
Query: 241 EGDSGGPLMIE---REDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
+GDSGGP + E W L G VS G CA PGVY + + ++ W+
Sbjct: 305 QGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWI 355
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 110 bits (275), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 61/171 (35%), Positives = 87/171 (50%), Gaps = 13/171 (7%)
Query: 128 NVRRVIVHRQY------DAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVAT 180
V+ V+ H Y ++ NDIAL+ L +P+ +I P+C+P G++ T
Sbjct: 71 GVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICT 130
Query: 181 VSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSC 240
V+GWG +Y G VLQE +VP+I N+VC + I CAGY G D+C
Sbjct: 131 VTGWGNTQYYGQQAGVLQEARVPIISNDVCNG---ADFYGNQIKPKMFCAGYPEGGIDAC 187
Query: 241 EGDSGGPLMIE---REDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
+GDSGGP + E W L G VS G CA PGVY + + ++ W+
Sbjct: 188 QGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWI 238
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 109 bits (272), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 61/161 (37%), Positives = 87/161 (54%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP-KDDDDFTGRVATVSGWGRL 187
V+ +I+H QY A DIALL+LET + Y PIC+P K D + V+GWG
Sbjct: 76 VQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRNVIYTDCWVTGWGYR 135
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
+ + LQ+ ++P++ N CQ+ ++ GH I + +CAGY G +D+C+GDSGGP
Sbjct: 136 ALRDKIQNTLQKAKIPLVTNEECQKRYR--GHK--ITHKMICAGYREGGKDACKGDSGGP 191
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L + + W L G S G CA PGVY Y W+
Sbjct: 192 LSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 108 bits (271), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 77/232 (33%), Positives = 116/232 (50%), Gaps = 28/232 (12%)
Query: 79 QFPQQDSMMTNFDMFT----INLSKIGFLANLV-------AVFGEYDISGELEAKRSISK 127
QFP Q + D F IN + A+ + V GEY+ E E +
Sbjct: 11 QFPWQVLLNGKIDAFCGGSIINEKWVVTAAHCIEPGVKITVVAGEYNTE-ETEPTEQ-RR 68
Query: 128 NVRRVIVHRQYDAAT--FENDIALLELETPIAYDSHIVPICMPKDDDDFTGRV-----AT 180
NV R I H Y+A + +DIALLEL+ P+ +S++ PIC+ D ++T
Sbjct: 69 NVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPICIA--DKEYTNIFLKFGSGY 126
Query: 181 VSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSC 240
VSGWGR+ G ++LQ ++VP+++ C + TI ++ CAG+ G +DSC
Sbjct: 127 VSGWGRVFNRGRSATILQYLKVPLVDRATCLRSTKF-----TIYSNMFCAGFHEGGKDSC 181
Query: 241 EGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
+GDSGGP + E E G L G +S G +CA G+Y + + Y W++ T
Sbjct: 182 QGDSGGPHVTEVE-GTSFLTGIISWGEECAVKGKYGIYTKVSRYVNWIKEKT 232
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 108 bits (269), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 60/170 (35%), Positives = 87/170 (51%), Gaps = 7/170 (4%)
Query: 127 KNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDF-TGRVATVSGWG 185
++ +I H Y + DIALL+L PI + +I PI +P + F G TV+GWG
Sbjct: 71 STLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAANASFPNGLHCTVTGWG 130
Query: 186 RLKYGGGV--PSVLQEVQVPVIENNVCQEMFQTAGHAKT---IINSFLCAGYANGQRDSC 240
+ + P LQ+++VP+I C ++ + + +CAGY G +D+C
Sbjct: 131 HVAPSVSLLTPKPLQQLEVPLISRETCNALYNIDAKPEEPHFVQEDMVCAGYVEGGKDAC 190
Query: 241 EGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
+GDSGGPL E G W L G VS G C A PGVY + Y W+Q+
Sbjct: 191 QGDSGGPLSCPVE-GLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQS 239
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 108 bits (269), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 61/161 (37%), Positives = 87/161 (54%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP-KDDDDFTGRVATVSGWGRL 187
V+ +I+H QY A DIALL+LET + Y PI +P K D + V+GWG
Sbjct: 76 VQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYR 135
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
K + + LQ+ ++P++ N CQ+ ++ GH I + +CAGY G +D+C+GDSGGP
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYR--GHK--ITHKMICAGYREGGKDACKGDSGGP 191
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L + + W L G S G CA PGVY Y W+
Sbjct: 192 LSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 108 bits (269), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 60/170 (35%), Positives = 86/170 (50%), Gaps = 7/170 (4%)
Query: 127 KNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDF-TGRVATVSGWG 185
++ +I H Y + DIALL+L PI + +I PI +P F G TV+GWG
Sbjct: 71 STLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPNGLHCTVTGWG 130
Query: 186 RLKYGGGV--PSVLQEVQVPVIENNVCQEMFQTAGHAKT---IINSFLCAGYANGQRDSC 240
+ + P LQ+++VP+I C ++ + + +CAGY G +D+C
Sbjct: 131 HVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGKDAC 190
Query: 241 EGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
+GDSGGPL E G W L G VS G C A PGVY + Y W+Q+
Sbjct: 191 QGDSGGPLSCPVE-GLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQS 239
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 108 bits (269), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 60/170 (35%), Positives = 86/170 (50%), Gaps = 7/170 (4%)
Query: 127 KNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDF-TGRVATVSGWG 185
++ +I H Y + DIALL+L PI + +I PI +P F G TV+GWG
Sbjct: 71 STLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPNGLHCTVTGWG 130
Query: 186 RLKYGGGV--PSVLQEVQVPVIENNVCQEMFQTAGHAKT---IINSFLCAGYANGQRDSC 240
+ + P LQ+++VP+I C ++ + + +CAGY G +D+C
Sbjct: 131 HVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGKDAC 190
Query: 241 EGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
+GDSGGPL E G W L G VS G C A PGVY + Y W+Q+
Sbjct: 191 QGDSGGPLSCPVE-GLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQS 239
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 107 bits (268), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 61/161 (37%), Positives = 87/161 (54%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP-KDDDDFTGRVATVSGWGRL 187
V+ +I+H QY A DIALL+LET + Y PI +P K D + V+GWG
Sbjct: 76 VQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYR 135
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
K + + LQ+ ++P++ N CQ+ ++ GH I + +CAGY G +D+C+GDSGGP
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYR--GHK--ITHKMICAGYREGGKDACKGDSGGP 191
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L + + W L G S G CA PGVY Y W+
Sbjct: 192 LSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 107 bits (268), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 61/161 (37%), Positives = 87/161 (54%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP-KDDDDFTGRVATVSGWGRL 187
V+ +I+H QY A DIALL+LET + Y PI +P K D + V+GWG
Sbjct: 76 VQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYR 135
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
K + + LQ+ ++P++ N CQ+ ++ GH I + +CAGY G +D+C+GDSGGP
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYR--GHK--ITHKMICAGYREGGKDACKGDSGGP 191
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L + + W L G S G CA PGVY Y W+
Sbjct: 192 LSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 107 bits (268), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 61/161 (37%), Positives = 87/161 (54%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP-KDDDDFTGRVATVSGWGRL 187
V+ +I+H QY A DIALL+LET + Y PI +P K D + V+GWG
Sbjct: 76 VQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYR 135
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
K + + LQ+ ++P++ N CQ+ ++ GH I + +CAGY G +D+C+GDSGGP
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYR--GHK--ITHKMICAGYREGGKDACKGDSGGP 191
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L + + W L G S G CA PGVY Y W+
Sbjct: 192 LSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 107 bits (267), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 61/161 (37%), Positives = 87/161 (54%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP-KDDDDFTGRVATVSGWGRL 187
V+ +I+H QY A DIALL+LET + Y PI +P K D + V+GWG
Sbjct: 76 VQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGYR 135
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
K + + LQ+ ++P++ N CQ+ ++ GH I + +CAGY G +D+C+GDSGGP
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYR--GHK--ITHKMICAGYREGGKDACKGDSGGP 191
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L + + W L G S G CA PGVY Y W+
Sbjct: 192 LSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 106 bits (264), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 60/161 (37%), Positives = 87/161 (54%), Gaps = 6/161 (3%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP-KDDDDFTGRVATVSGWGRL 187
V+ +I+H QY A DIALL+LET + Y PI +P K + + V+GWG
Sbjct: 76 VQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGERNVIYTDCWVTGWGYR 135
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
K + + LQ+ ++P++ N CQ+ ++ GH I + +CAGY G +D+C+GDSGGP
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYR--GHK--ITHKMICAGYREGGKDACKGDSGGP 191
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
L + + W L G S G CA PGVY Y W+
Sbjct: 192 LSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 105 bits (263), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 73/237 (30%), Positives = 112/237 (47%), Gaps = 19/237 (8%)
Query: 66 PPPTVSRHTLYTLQFPQQDSMMTNFDMFTINLSKIGFLANLVAVF--------GEYDISG 117
P V Y +P Q S+ T F M + I L A Y +
Sbjct: 15 PGAVVGGCVAYPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVIL 74
Query: 118 ELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGR 177
+ ++ +V+ + V R + T DIALL+L +P ++P C+P + R
Sbjct: 75 GAHQEVNLEPHVQEIEVSRLFLEPT-RKDIALLKLSSPAVITDKVIPACLPSPNYVVADR 133
Query: 178 VAT-VSGWGRLK--YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYAN 234
++GWG + +G G+ L E Q+PVIEN VC G ++ + LCAG+
Sbjct: 134 TECFITGWGETQGTFGAGL---LMEAQLPVIENKVCNRYEFLNGRVQS---TELCAGHLA 187
Query: 235 GQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
G DSC+GDSGGPL+ +D ++L G S G+ CA P PGVY+R + + W++ +
Sbjct: 188 GGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 243
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 13/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I +++ IS + RVI H Y + +NDI L++L P ++++ P+ +P
Sbjct: 50 LGEHNIKVTEGSEQFISSS--RVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPS 107
Query: 170 DDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
G + TVSGWG + LQ + +P++ + C + I N+ C
Sbjct: 108 SCAP-AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSY-----PGMITNAMFC 161
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
AGY G +DSC+GDSGGP++ E L G VS G CA P PGVY + + WL
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNNWLT 216
Query: 290 T 290
+
Sbjct: 217 S 217
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 70/224 (31%), Positives = 110/224 (49%), Gaps = 19/224 (8%)
Query: 79 QFPQQDSMMTNFDMFTINLSKIGFLANLVAVF--------GEYDISGELEAKRSISKNVR 130
+P Q S+ T F M + I L A Y + + ++ +V+
Sbjct: 31 SWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQ 90
Query: 131 RVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVAT-VSGWGRLK- 188
+ V R + T DIALL+L +P ++P C+P + R ++GWG +
Sbjct: 91 EIEVSRLFLEPT-RKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQG 149
Query: 189 -YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
+G G+ L+E Q+PVIEN VC G ++ + LCAG+ G DSC+GDSGGP
Sbjct: 150 TFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS---TELCAGHLAGGTDSCQGDSGGP 203
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
L+ +D ++L G S G+ CA P PGVY+R + + W++ +
Sbjct: 204 LVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 246
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 13/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I +++ IS + RVI H Y + +NDI L++L P ++++ P+ +P
Sbjct: 50 LGEHNIKVTEGSEQFISSS--RVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPT 107
Query: 170 DDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
G + TVSGWG + LQ + +P++ + C + I N+ C
Sbjct: 108 SCAP-AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSY-----PGMITNAMFC 161
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
AGY G +DSC+GDSGGP++ E L G VS G CA P PGVY + + WL
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLT 216
Query: 290 T 290
+
Sbjct: 217 S 217
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 13/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I +++ IS + RVI H Y + +NDI L++L P ++++ P+ +P
Sbjct: 50 LGEHNIKVTEGSEQFISSS--RVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPS 107
Query: 170 DDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
G + TVSGWG + LQ + +P++ + C + I N+ C
Sbjct: 108 SCAP-AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSY-----PGMITNAMFC 161
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
AGY G +DSC+GDSGGP++ E L G VS G CA P PGVY + + WL
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLT 216
Query: 290 T 290
+
Sbjct: 217 S 217
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 70/224 (31%), Positives = 110/224 (49%), Gaps = 19/224 (8%)
Query: 79 QFPQQDSMMTNFDMFTINLSKIGFLANLVAVF--------GEYDISGELEAKRSISKNVR 130
+P Q S+ T F M + I L A Y + + ++ +V+
Sbjct: 28 SWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQ 87
Query: 131 RVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVAT-VSGWGRLK- 188
+ V R + T DIALL+L +P ++P C+P + R ++GWG +
Sbjct: 88 EIEVSRLFLEPT-RKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQG 146
Query: 189 -YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
+G G+ L+E Q+PVIEN VC G ++ + LCAG+ G DSC+GDSGGP
Sbjct: 147 TFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS---TELCAGHLAGGTDSCQGDSGGP 200
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
L+ +D ++L G S G+ CA P PGVY+R + + W++ +
Sbjct: 201 LVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 243
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 13/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I +++ IS + RVI H Y + +NDI L++L P ++++ P+ +P
Sbjct: 70 LGEHNIKVTEGSEQFISSS--RVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPT 127
Query: 170 DDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
G + TVSGWG + LQ + +P++ + C + I N+ C
Sbjct: 128 SCAP-AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSY-----PGMITNAMFC 181
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
AGY G +DSC+GDSGGP++ E L G VS G CA P PGVY + + WL
Sbjct: 182 AGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLT 236
Query: 290 T 290
+
Sbjct: 237 S 237
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 59/181 (32%), Positives = 92/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I LE N ++I H ++ T +NDI L++L +P +S + + +P+
Sbjct: 50 LGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR 107
Query: 170 DDDDFTGRVATVSGWGRLKYGGG-VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG K G PS+LQ ++ PV+ N+ C+ + I + +
Sbjct: 108 SCAA-AGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSNSSCKSSY-----PGQITGNMI 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ + L G VS G CA PGVY + Y W+
Sbjct: 162 CVGFLQGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 13/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I +++ IS + RVI H Y + +NDI L++L P ++++ P+ +P
Sbjct: 50 LGEHNIKVTEGSEQFISSS--RVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPT 107
Query: 170 DDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
G + TVSGWG + LQ + +P++ + C + I N+ C
Sbjct: 108 SCAP-AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSY-----PGMITNAMFC 161
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
AGY G +DSC+GDSGGP++ E L G VS G CA P PGVY + + WL
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLT 216
Query: 290 T 290
+
Sbjct: 217 S 217
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 13/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I +++ IS + RVI H Y + +NDI L++L P ++++ P+ +P
Sbjct: 50 LGEHNIKVTEGSEQFISSS--RVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPT 107
Query: 170 DDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
G + TVSGWG LQ + +P++ + C + + I N+ C
Sbjct: 108 SCAP-AGTMCTVSGWGNTMSSTADSDKLQCLNIPILSYSDCNDSY-----PGMITNAMFC 161
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
AGY G +DSC+GDSGGP++ E L G VS G CA P PGVY + + WL
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFSDWLT 216
Query: 290 T 290
+
Sbjct: 217 S 217
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 13/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I +++ IS + RVI H Y + +NDI L++L P ++++ P+ +P
Sbjct: 65 LGEHNIKVTEGSEQFISSS--RVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPT 122
Query: 170 DDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
G + TVSGWG + LQ + +P++ + C + I N+ C
Sbjct: 123 SCAP-AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYP-----GMITNAMFC 176
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
AGY G +DSC+GDSGGP++ E L G VS G CA P PGVY + + WL
Sbjct: 177 AGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLT 231
Query: 290 T 290
+
Sbjct: 232 S 232
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 63/185 (34%), Positives = 94/185 (50%), Gaps = 14/185 (7%)
Query: 107 VAV-FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPI 165
VAV GE++I +++ IS + RVI H Y + +NDI L++L P ++++ P+
Sbjct: 46 VAVRLGEHNIKVTEGSEQFISSS--RVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPV 103
Query: 166 CMPKDDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN 225
+P G + TVSGWG LQ + +P++ + C + I N
Sbjct: 104 ALPSSCAP-AGTMCTVSGWGNTMSSTADGDKLQCLNIPILSYSDCNNSY-----PGMITN 157
Query: 226 SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYK 285
+ CAGY G +DSC+GDSGGP++ E L G VS G CA P PGVY + +
Sbjct: 158 AMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFN 212
Query: 286 PWLQT 290
WL +
Sbjct: 213 DWLTS 217
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 96/194 (49%), Gaps = 18/194 (9%)
Query: 106 LVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPI 165
L+ GEYD+ K + +++ V VH Y +T +NDIALL L P IVPI
Sbjct: 50 LLVRLGEYDL--RRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPI 107
Query: 166 CMPKD-----DDDFTGRVATVSGWG----RLKYGG-GVPSVLQEVQVPVIENNVCQEMFQ 215
C+P + + G+ V+GWG R K VL +++PV+ +N C E+
Sbjct: 108 CLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVM- 166
Query: 216 TAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLP 275
+ + + LCAG ++D+CEGDSGGP M+ G W L G VS G C +
Sbjct: 167 ----SNMVSENMLCAGILGDRQDACEGDSGGP-MVASFHGTWFLVGLVSWGEGCGLLHNY 221
Query: 276 GVYMRTTYYKPWLQ 289
GVY + + Y W+
Sbjct: 222 GVYTKVSRYLDWIH 235
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 66/195 (33%), Positives = 97/195 (49%), Gaps = 18/195 (9%)
Query: 105 NLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVP 164
L+ GEYD+ K + +++ V VH Y +T +NDIALL L P IVP
Sbjct: 49 KLLVRLGEYDL--RRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVP 106
Query: 165 ICMPKD-----DDDFTGRVATVSGWG----RLKYGGGVPS-VLQEVQVPVIENNVCQEMF 214
IC+P + + G+ V+GWG R K + VL +++PV+ +N C E+
Sbjct: 107 ICLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVM 166
Query: 215 QTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYL 274
+ + + LCAG ++D+CEGDSGGP M+ G W L G VS G C +
Sbjct: 167 -----SNMVSENMLCAGILGDRQDACEGDSGGP-MVASFHGTWFLVGLVSWGEGCGLLHN 220
Query: 275 PGVYMRTTYYKPWLQ 289
GVY + + Y W+
Sbjct: 221 YGVYTKVSRYLDWIH 235
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 69/224 (30%), Positives = 110/224 (49%), Gaps = 19/224 (8%)
Query: 79 QFPQQDSMMTNFDMFTINLSKIGFLANLVAVF--------GEYDISGELEAKRSISKNVR 130
+P Q S+ T F M + I L A Y + + ++ +V+
Sbjct: 31 SWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQ 90
Query: 131 RVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVAT-VSGWGRLK- 188
+ V R + T DIALL+L +P ++P C+P + R ++GWG +
Sbjct: 91 EIEVSRLFLEPT-RKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQG 149
Query: 189 -YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
+G G+ L+E Q+PVIEN VC G ++ + LCAG+ G DSC+GD+GGP
Sbjct: 150 TFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS---TELCAGHLAGGTDSCQGDAGGP 203
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
L+ +D ++L G S G+ CA P PGVY+R + + W++ +
Sbjct: 204 LVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 246
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 104 bits (260), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 102 FLANLVAV---FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAY 158
+ +NL A+ GE+D E E + +R+VI+H ++ T ND+ALL L+ P+
Sbjct: 184 YQSNLDAIKIRAGEWDTLTEKERLPYQERKIRQVIIHSNFNPKTVVNDVALLLLDRPLVQ 243
Query: 159 DSHIVPICMPKDDDDFTGRVATVSGWGRLKYGG--GVPSVLQEVQVPVIENNVCQEMFQT 216
+I IC+P+ F SGWG+ ++G ++L+++Q+P ++ + CQ +
Sbjct: 244 ADNIGTICLPQQSQIFDSTECFASGWGKKEFGSRHRYSNILKKIQLPTVDRDKCQADLRN 303
Query: 217 A--GHAKTIINSFLCAGYANGQRDSCEGDSGGPLMI--EREDGHWVLAGTVSHGIKCAAP 272
G + +F+CAG G +D+C GD G PL R ++ G V+ GI C
Sbjct: 304 TRLGLKFVLDQTFVCAGGEQG-KDTCTGDGGSPLFCPDPRNPSRYMQMGIVAWGIGCGDE 362
Query: 273 YLPGVYMRTTYYKPWL 288
+PGVY +++ W+
Sbjct: 363 NVPGVYANVAHFRNWI 378
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 104 bits (260), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 69/224 (30%), Positives = 110/224 (49%), Gaps = 19/224 (8%)
Query: 79 QFPQQDSMMTNFDMFTINLSKIGFLANLVAVF--------GEYDISGELEAKRSISKNVR 130
+P Q S+ T F M + I L A Y + + ++ +V+
Sbjct: 29 SWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQ 88
Query: 131 RVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVAT-VSGWGRLK- 188
+ V R + T DIALL+L +P ++P C+P + R ++GWG +
Sbjct: 89 EIEVSRLFLEPT-RKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQG 147
Query: 189 -YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
+G G+ L+E Q+PVIEN VC G ++ + LCAG+ G DSC+GD+GGP
Sbjct: 148 TFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS---TELCAGHLAGGTDSCQGDAGGP 201
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
L+ +D ++L G S G+ CA P PGVY+R + + W++ +
Sbjct: 202 LVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 244
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 104 bits (260), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 69/224 (30%), Positives = 110/224 (49%), Gaps = 19/224 (8%)
Query: 79 QFPQQDSMMTNFDMFTINLSKIGFLANLVAVF--------GEYDISGELEAKRSISKNVR 130
+P Q S+ T F M + I L A Y + + ++ +V+
Sbjct: 30 SWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQ 89
Query: 131 RVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVAT-VSGWGRLK- 188
+ V R + T DIALL+L +P ++P C+P + R ++GWG +
Sbjct: 90 EIEVSRLFLEPT-RKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQG 148
Query: 189 -YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
+G G+ L+E Q+PVIEN VC G ++ + LCAG+ G DSC+GD+GGP
Sbjct: 149 TFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS---TELCAGHLAGGTDSCQGDAGGP 202
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
L+ +D ++L G S G+ CA P PGVY+R + + W++ +
Sbjct: 203 LVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 245
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 104 bits (259), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 60/171 (35%), Positives = 95/171 (55%), Gaps = 11/171 (6%)
Query: 124 SISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVAT-VS 182
++ +V+ + V R + T DIALL+L +P ++P C+P + R ++
Sbjct: 80 NLEPHVQEIEVSRLFLEPT-RKDIALLKLSSPAVITDKVIPACLPSPNYMVADRTECFIT 138
Query: 183 GWGRLK--YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSC 240
GWG + +G G+ L+E Q+PVIEN VC G ++ + LCAG+ G DSC
Sbjct: 139 GWGETQGTFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS---TELCAGHLAGGTDSC 192
Query: 241 EGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+GDSGGPL+ +D ++L G S G+ CA P PGVY+R + + W++ +
Sbjct: 193 QGDSGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 242
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 104 bits (259), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 69/224 (30%), Positives = 110/224 (49%), Gaps = 19/224 (8%)
Query: 79 QFPQQDSMMTNFDMFTINLSKIGFLANLVAVF--------GEYDISGELEAKRSISKNVR 130
+P Q S+ T F M + I L A Y + + ++ +V+
Sbjct: 28 SWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQ 87
Query: 131 RVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVAT-VSGWGRLK- 188
+ V R + T DIALL+L +P ++P C+P + R ++GWG +
Sbjct: 88 EIEVSRLFLEPT-RKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQG 146
Query: 189 -YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
+G G+ L+E Q+PVIEN VC G ++ + LCAG+ G DSC+GD+GGP
Sbjct: 147 TFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS---TELCAGHLAGGTDSCQGDAGGP 200
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
L+ +D ++L G S G+ CA P PGVY+R + + W++ +
Sbjct: 201 LVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 243
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 103 bits (257), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 58/166 (34%), Positives = 87/166 (52%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH YD+ T NDI L++L++ + DS + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYDSNTLNNDIMLIKLKSAASLDSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 103 bits (257), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 92/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I LE N ++I H ++ T +NDI L++L +P +S + + +P+
Sbjct: 50 LGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR 107
Query: 170 DDDDFTGRVATVSGWGRLKYGGG-VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG K G PS+LQ ++ PV+ ++ C+ + I + +
Sbjct: 108 SCAA-AGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSAY-----PGQITGNMI 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ + L G VS G CA PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 103 bits (256), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 92/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I LE N ++I H ++ T +NDI L++L +P +S + + +P+
Sbjct: 50 LGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR 107
Query: 170 DDDDFTGRVATVSGWGRLKYGGG-VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG K G PS+LQ ++ PV+ ++ C+ + I + +
Sbjct: 108 SCAA-AGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY-----PGQITGNMI 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ + L G VS G CA PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 103 bits (256), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 70/223 (31%), Positives = 110/223 (49%), Gaps = 19/223 (8%)
Query: 80 FPQQDSMMTNFDMFTINLSKIGFLANLVAVF--------GEYDISGELEAKRSISKNVRR 131
+P Q S+ T F M + I L A Y + + ++ +V+
Sbjct: 573 WPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQE 632
Query: 132 VIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVAT-VSGWGRLK-- 188
+ V R + T DIALL+L +P ++P C+P + R ++GWG +
Sbjct: 633 IEVSRLFLEPT-RKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGT 691
Query: 189 YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPL 248
+G G+ L+E Q+PVIEN VC G ++ + LCAG+ G DSC+GDSGGPL
Sbjct: 692 FGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS---TELCAGHLAGGTDSCQGDSGGPL 745
Query: 249 MIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+ +D ++L G S G+ CA P PGVY+R + + W++ +
Sbjct: 746 VCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 787
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 103 bits (256), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 92/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I LE N ++I H ++ T +NDI L++L +P +S + + +P+
Sbjct: 50 LGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR 107
Query: 170 DDDDFTGRVATVSGWGRLKYGGG-VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG K G PS+LQ ++ PV+ ++ C+ + I + +
Sbjct: 108 SCAA-AGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY-----PGQITGNMI 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ + L G VS G CA PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 92/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I LE N ++I H ++ T +NDI L++L +P +S + + +P+
Sbjct: 58 LGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR 115
Query: 170 DDDDFTGRVATVSGWGRLKYGGG-VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG K G PS+LQ ++ PV+ ++ C+ + I + +
Sbjct: 116 SCA-AAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY-----PGQITGNMI 169
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ + L G VS G CA PGVY + Y W+
Sbjct: 170 CVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 224
Query: 289 Q 289
Q
Sbjct: 225 Q 225
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 102 bits (255), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++H+ + +P
Sbjct: 72 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATVALPS 129
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 130 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 183
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 184 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 238
Query: 289 Q 289
Q
Sbjct: 239 Q 239
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 102 bits (255), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 59/181 (32%), Positives = 91/181 (50%), Gaps = 13/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I +++ IS + RVI H Y + +NDI L++L ++++ P+ +P
Sbjct: 50 LGEHNIKVTEGSEQFISSS--RVIRHPNYSSYNIDNDIMLIKLSKSATLNTYVQPVALPS 107
Query: 170 DDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
G + TVSGWG + LQ + +P++ + C + I N+ C
Sbjct: 108 SCAP-AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSY-----PGMITNAMFC 161
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
AGY G +DSC+GDSGGP++ E L G VS G CA P PGVY + + WL
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLT 216
Query: 290 T 290
+
Sbjct: 217 S 217
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 102 bits (253), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I LE N ++I H ++ T +NDI L++L +P S + + +P+
Sbjct: 50 LGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDNDIMLIKLSSPATLXSRVATVSLPR 107
Query: 170 DDDDFTGRVATVSGWGRLKYGGG-VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG K G PS+LQ ++ PV+ ++ C+ + I + +
Sbjct: 108 SCAA-AGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY-----PGQITGNMI 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ + L G VS G CA PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 101 bits (252), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 63/187 (33%), Positives = 99/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C PG Y
Sbjct: 187 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKPGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 101 bits (251), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 56/166 (33%), Positives = 88/166 (53%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 101 bits (251), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 59/167 (35%), Positives = 93/167 (55%), Gaps = 8/167 (4%)
Query: 132 VIVHRQY-DAATFENDIALLELETPIAYDSHIVPICMP-KDDDDF--TGRVATVSGWGRL 187
V +H Y A F+NDIAL++L + +S+I PIC+P K+ + F T + T SGWG L
Sbjct: 73 VFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWG-L 131
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAK-TIINSFLCAGYANGQRDSCEGDSGG 246
G + L V +P++++ C ++ + + ++ + LCAG +G +DSC GDSGG
Sbjct: 132 TQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGG 191
Query: 247 PLM-IEREDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTYYKPWLQTI 291
L+ ++ E W + G VS G + C GVY + Y PW++ I
Sbjct: 192 ALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPWIENI 238
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 101 bits (251), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 61/181 (33%), Positives = 97/181 (53%), Gaps = 16/181 (8%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA- 233
G V+GWG LK G PSVLQ V +P++E VC++ + I ++ CAGY
Sbjct: 132 AGYKGRVTGWGNLKETWGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKP 186
Query: 234 -NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
G+R D+CEGDSGGP +++ + W G VS G C G Y K W+Q
Sbjct: 187 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 246
Query: 291 I 291
+
Sbjct: 247 V 247
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 100 bits (250), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 59/167 (35%), Positives = 93/167 (55%), Gaps = 8/167 (4%)
Query: 132 VIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMP-KDDDDF--TGRVATVSGWGRL 187
V +H Y A F+NDIAL++L + +S+I PIC+P K+ + F T + T SGWG L
Sbjct: 159 VFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWG-L 217
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAK-TIINSFLCAGYANGQRDSCEGDSGG 246
G + L V +P++++ C ++ + + ++ + LCAG +G +DSC GDSGG
Sbjct: 218 TQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGG 277
Query: 247 PLM-IEREDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTYYKPWLQTI 291
L+ ++ E W + G VS G + C GVY + Y PW++ I
Sbjct: 278 ALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPWIENI 324
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 100 bits (249), Expect = 9e-22, Method: Compositional matrix adjust.
Identities = 60/178 (33%), Positives = 94/178 (52%), Gaps = 20/178 (11%)
Query: 129 VRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT----GRVATVSG 183
+ ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + + G V+G
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTG 140
Query: 184 WGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--NG 235
WG LK G G PSVLQ V +P++E VC++ + I ++ CAGY G
Sbjct: 141 WGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKPDEG 195
Query: 236 QR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+R D+CEGDSGGP +++ + W G VS G CA G Y K W+Q +
Sbjct: 196 KRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCARKGKYGFYTHVFRLKKWIQKV 253
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 56/166 (33%), Positives = 87/166 (52%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 56/166 (33%), Positives = 87/166 (52%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 57/170 (33%), Positives = 92/170 (54%), Gaps = 7/170 (4%)
Query: 123 RSISKNVRRVIVHRQYDAATFE--NDIALLELETPIAYDSHIVPICMPKDDDDF-TGRVA 179
+ I + I H Y + + +DIAL+ L + + ++I P+C+P+ +++ G+
Sbjct: 108 KPIDLGIEETIQHPDYVDGSKDRYHDIALIRLNRQVEFTNYIRPVCLPQPNEEVQVGQRL 167
Query: 180 TVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
TV GWGR + G ++ Q++ VPV+ C + F AG + +S LCAG +DS
Sbjct: 168 TVVGWGRTETGQ-YSTIKQKLAVPVVHAEQCAKTFGAAG--VRVRSSQLCAG-GEKAKDS 223
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
C GDSGGPL+ ER + + L G VS G C PG+Y + Y+ W++
Sbjct: 224 CGGDSGGPLLAERANQQFFLEGLVSFGATCGTEGWPGIYTKVGKYRDWIE 273
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 59/167 (35%), Positives = 93/167 (55%), Gaps = 8/167 (4%)
Query: 132 VIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMP-KDDDDF--TGRVATVSGWGRL 187
V +H Y A F+NDIAL++L + +S+I PIC+P K+ + F T + T SGWG L
Sbjct: 234 VFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWG-L 292
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAK-TIINSFLCAGYANGQRDSCEGDSGG 246
G + L V +P++++ C ++ + + ++ + LCAG +G +DSC GDSGG
Sbjct: 293 TQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGG 352
Query: 247 PLM-IEREDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTYYKPWLQTI 291
L+ ++ E W + G VS G + C GVY + Y PW++ I
Sbjct: 353 ALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPWIENI 399
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 58/167 (34%), Positives = 93/167 (55%), Gaps = 8/167 (4%)
Query: 132 VIVHRQY-DAATFENDIALLELETPIAYDSHIVPICMP-KDDDDF--TGRVATVSGWGRL 187
V +H Y A F+NDIAL++L + +S+I PIC+P K+ + F T + T SGWG L
Sbjct: 73 VFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWG-L 131
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAK-TIINSFLCAGYANGQRDSCEGDSGG 246
G + L V +P++++ C ++ + + ++ + LCAG +G +DSC GD+GG
Sbjct: 132 TQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDAGG 191
Query: 247 PLM-IEREDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTYYKPWLQTI 291
L+ ++ E W + G VS G + C GVY + Y PW++ I
Sbjct: 192 ALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPWIENI 238
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 56/166 (33%), Positives = 87/166 (52%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 80 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 138
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GDSGG
Sbjct: 139 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDSGG 193
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 194 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 234
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 59/181 (32%), Positives = 92/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T+ NDI L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 56/166 (33%), Positives = 87/166 (52%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 72 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 130
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GDSGG
Sbjct: 131 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDSGG 185
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 186 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 226
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 56/166 (33%), Positives = 87/166 (52%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 71 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 129
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GDSGG
Sbjct: 130 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDSGG 184
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 185 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 225
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 56/166 (33%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + C+ + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILSTSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 56/166 (33%), Positives = 87/166 (52%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 86 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 144
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GDSGG
Sbjct: 145 KSSGTSYPDVLKCLKAPILSDSSCKSAYP-----GQITSNMFCAGYLEGGKDSCQGDSGG 199
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 200 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 240
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 60/181 (33%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + I +P
Sbjct: 50 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATIALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 99.8 bits (247), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 58/179 (32%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 114 DISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD-- 171
D + E E V VI H ++ T++ DIA+L L+TPI + ++ P C+P+ D
Sbjct: 71 DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWA 130
Query: 172 --DDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
T + VSG+GR G + L+ ++VP ++ N C+ + I + C
Sbjct: 131 ESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-----LSSSFIITQNMFC 185
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
AGY Q D+C+GDSGGP + +D ++V G VS G CA G+Y + T + W+
Sbjct: 186 AGYDTKQEDACQGDSGGPHVTRFKDTYFV-TGIVSWGEGCARKGKYGIYTKVTAFLKWI 243
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 57/182 (31%), Positives = 94/182 (51%), Gaps = 10/182 (5%)
Query: 114 DISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD-- 171
D + E E ++ V + H ++ T++ DIA+L L+TPI + ++ P C+P+ D
Sbjct: 56 DRNTEQEEGNEMAHEVEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAPACLPEKDWA 115
Query: 172 --DDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
T + VSG+GR G + S L+ ++VP ++ + C+ + TI + C
Sbjct: 116 EATLMTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCK-----LSSSFTITPNMFC 170
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
AGY D+C+GDSGGP + +D ++V G VS G CA GVY + + + W+
Sbjct: 171 AGYDTQPEDACQGDSGGPHVTRFKDTYFV-TGIVSWGEGCARKGKFGVYTKVSNFLKWID 229
Query: 290 TI 291
I
Sbjct: 230 KI 231
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 58/179 (32%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 114 DISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD-- 171
D + E E V VI H ++ T++ DIA+L L+TPI + ++ P C+P+ D
Sbjct: 56 DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWA 115
Query: 172 --DDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
T + VSG+GR G + L+ ++VP ++ N C+ + I + C
Sbjct: 116 ESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-----LSSSFIITQNMFC 170
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
AGY Q D+C+GDSGGP + +D ++V G VS G CA G+Y + T + W+
Sbjct: 171 AGYDTKQEDACQGDSGGPHVTRFKDTYFV-TGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 59/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 58/179 (32%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 114 DISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD-- 171
D + E E V VI H ++ T++ DIA+L L+TPI + ++ P C+P+ D
Sbjct: 56 DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWA 115
Query: 172 --DDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
T + VSG+GR G + L+ ++VP ++ N C+ + I + C
Sbjct: 116 ESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-----LSSSFIITQNMFC 170
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
AGY Q D+C+GDSGGP + +D ++V G VS G CA G+Y + T + W+
Sbjct: 171 AGYDTKQEDACQGDSGGPHVTRFKDTYFV-TGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 58/179 (32%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 114 DISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD-- 171
D + E E V VI H ++ T++ DIA+L L+TPI + ++ P C+P+ D
Sbjct: 56 DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWA 115
Query: 172 --DDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
T + VSG+GR G + L+ ++VP ++ N C+ + I + C
Sbjct: 116 ESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-----LSSSFIITQNMFC 170
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
AGY Q D+C+GDSGGP + +D ++V G VS G CA G+Y + T + W+
Sbjct: 171 AGYDTKQEDACQGDSGGPHVTRFKDTYFV-TGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 58/179 (32%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 114 DISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD-- 171
D + E E V VI H ++ T++ DIA+L L+TPI + ++ P C+P+ D
Sbjct: 56 DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWA 115
Query: 172 --DDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
T + VSG+GR G + L+ ++VP ++ N C+ + I + C
Sbjct: 116 ESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCK-----LSSSFIITQNMFC 170
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
AGY Q D+C+GDSGGP + +D ++V G VS G CA G+Y + T + W+
Sbjct: 171 AGYDTKQEDACQGDSGGPHVTRFKDTYFV-TGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 58/179 (32%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 114 DISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD-- 171
D + E E V VI H ++ T++ DIA+L L+TPI + ++ P C+P+ D
Sbjct: 56 DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWA 115
Query: 172 --DDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
T + VSG+GR G + L+ ++VP ++ N C+ + I + C
Sbjct: 116 ESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-----LSSSFIITQNMFC 170
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
AGY Q D+C+GDSGGP + +D ++V G VS G CA G+Y + T + W+
Sbjct: 171 AGYDTKQEDACQGDSGGPHVTRFKDTYFV-TGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 58/179 (32%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 114 DISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD-- 171
D + E E V VI H ++ T++ DIA+L L+TPI + ++ P C+P+ D
Sbjct: 56 DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWA 115
Query: 172 --DDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
T + VSG+GR G + L+ ++VP ++ N C+ + I + C
Sbjct: 116 ESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCK-----LSSSFIITQNMFC 170
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
AGY Q D+C+GDSGGP + +D ++V G VS G CA G+Y + T + W+
Sbjct: 171 AGYDTKQEDACQGDSGGPHVTRFKDTYFV-TGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 55/164 (33%), Positives = 87/164 (53%), Gaps = 10/164 (6%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD----DDFTGRVATVSGW 184
V VI H ++ T++ DIA+L L+TPI + ++ P C+P+ D T + VSG+
Sbjct: 71 VEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGF 130
Query: 185 GRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDS 244
GR G + L+ ++VP ++ N C+ + I + CAGY Q D+C+GDS
Sbjct: 131 GRTHEKGRQSTRLKMLEVPYVDRNSCK-----LSSSFIITQNMFCAGYDTKQEDACQGDS 185
Query: 245 GGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
GGP + +D ++V G VS G CA G+Y + T + W+
Sbjct: 186 GGPHVTRFKDTYFV-TGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 58/179 (32%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 114 DISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD-- 171
D + E E V VI H ++ T++ DIA+L L+TPI + ++ P C+P+ D
Sbjct: 56 DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWA 115
Query: 172 --DDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
T + VSG+GR G + L+ ++VP ++ N C+ + I + C
Sbjct: 116 ESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-----LSSSFIITQNMFC 170
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
AGY Q D+C+GDSGGP + +D ++V G VS G CA G+Y + T + W+
Sbjct: 171 AGYDTKQEDACQGDSGGPHVTRFKDTYFV-TGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 59/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDHKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 58/179 (32%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 114 DISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD-- 171
D + E E V VI H ++ T++ DIA+L L+TPI + ++ P C+P+ D
Sbjct: 56 DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWA 115
Query: 172 --DDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
T + VSG+GR G + L+ ++VP ++ N C+ + I + C
Sbjct: 116 ESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-----LSSSFIITQNMFC 170
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
AGY Q D+C+GDSGGP + +D ++V G VS G CA G+Y + T + W+
Sbjct: 171 AGYDTKQEDACQGDSGGPHVTRFKDTYFV-TGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 55/164 (33%), Positives = 87/164 (53%), Gaps = 10/164 (6%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD----DDFTGRVATVSGW 184
V VI H ++ T++ DIA+L L+TPI + ++ P C+P+ D T + VSG+
Sbjct: 71 VEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGF 130
Query: 185 GRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDS 244
GR G + L+ ++VP ++ N C+ + I + CAGY Q D+C+GDS
Sbjct: 131 GRTHEKGRQSTRLKMLEVPYVDRNSCK-----LSSSFIITQNMFCAGYDTKQEDACQGDS 185
Query: 245 GGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
GGP + +D ++V G VS G CA G+Y + T + W+
Sbjct: 186 GGPHVTRFKDTYFV-TGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 59/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 60 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 117
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 118 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 171
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 172 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 226
Query: 289 Q 289
Q
Sbjct: 227 Q 227
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 99.4 bits (246), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 87/166 (52%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + + +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASVSLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCAGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 99.4 bits (246), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 59/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 99.4 bits (246), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 59/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 58 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 115
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 116 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 169
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 170 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 224
Query: 289 Q 289
Q
Sbjct: 225 Q 225
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 99.4 bits (246), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 56/166 (33%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLXSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 99.0 bits (245), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 59/178 (33%), Positives = 93/178 (52%), Gaps = 20/178 (11%)
Query: 129 VRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT----GRVATVSG 183
+ ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + + G V+G
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTG 140
Query: 184 WGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--NG 235
WG LK G G PSVLQ V +P++E VC++ + I ++ CAGY G
Sbjct: 141 WGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKPDEG 195
Query: 236 QR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+R D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 196 KRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 99.0 bits (245), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 87/166 (52%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 86 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 144
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GD+GG
Sbjct: 145 KSSGTSYPDVLKCLKAPILSDSSCKSAYP-----GQITSNMFCAGYLEGGKDSCQGDAGG 199
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 200 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 240
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 99.0 bits (245), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GD GG
Sbjct: 125 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDXGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GD+GGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDAGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 92/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T+ NDI L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGNEQF-VNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASSSFIITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +D+C+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKDACQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 58/171 (33%), Positives = 93/171 (54%), Gaps = 7/171 (4%)
Query: 127 KNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP--KDDDDFTGRVATVSGW 184
+ V ++I+H +Y A++ NDIAL+++ P+ I P C+P + + V+GW
Sbjct: 82 RYVEKIIIHEKYSASSEANDIALMKITPPVTCGHFIGPGCLPQFRAGPPRVPQTCWVAGW 141
Query: 185 GRLKYGGGVPS-VLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGD 243
G L+ S +LQE +V +I+ +C T + I ++ +CAGY G+ D+C+GD
Sbjct: 142 GFLQENARRTSPMLQEARVDLIDLGLCNS---TRWYNGRIRSTNVCAGYPEGKIDTCQGD 198
Query: 244 SGGPLMI-EREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTITG 293
SGGPLM + + +V+ G S G+ CA PGVY T Y W+ + G
Sbjct: 199 SGGPLMCKDSAENSYVVVGITSWGVGCARAKRPGVYTSTWSYLNWIASKIG 249
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 61/169 (36%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP--KDDDDFTGRVATVSGWGR 186
V +I+H +Y + NDIAL+++ P+ I P C+P K + V+GWG
Sbjct: 84 VEEIIIHEKYVSGLEINDIALIKITPPVPCGPFIGPGCLPQFKAGPPRAPQTCWVTGWGY 143
Query: 187 LKYGGGVPS-VLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSG 245
LK G S LQE +V +I+ +C T + I ++ +CAGY G+ D+C+GDSG
Sbjct: 144 LKEKGPRTSPTLQEARVALIDLELCNS---TRWYNGRIRSTNVCAGYPRGKIDTCQGDSG 200
Query: 246 GPLMI-EREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTITG 293
GPLM +R + +V+ G S G+ CA PGVY T Y W+ + G
Sbjct: 201 GPLMCRDRAENTFVVVGITSWGVGCARAKRPGVYTSTWPYLNWIASKIG 249
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 108 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 167
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 168 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 222
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 223 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 282
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 283 KKWIQKV 289
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 104 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 163
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 164 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 218
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 219 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 278
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 279 KKWIQKV 285
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 60 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 117
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 118 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 171
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GD+GGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 172 CVGFLEGGKDSCQGDAGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 226
Query: 289 Q 289
Q
Sbjct: 227 Q 227
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 57/179 (31%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 114 DISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDD-- 171
D + E E V VI H ++ T++ DIA+L L+TPI + ++ P C+P+ D
Sbjct: 56 DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWA 115
Query: 172 --DDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLC 229
T + VSG+GR G + L+ ++VP ++ N C+ + I + C
Sbjct: 116 ESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-----LSSSFIITQNMFC 170
Query: 230 AGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
AGY Q D+C+GD+GGP + +D ++V G VS G CA G+Y + T + W+
Sbjct: 171 AGYDTKQEDACQGDAGGPHVTRFKDTYFV-TGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 59/178 (33%), Positives = 93/178 (52%), Gaps = 20/178 (11%)
Query: 129 VRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT----GRVATVSG 183
+ ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + + G V+G
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTG 140
Query: 184 WGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--NG 235
WG LK G G PSVLQ V +P++E VC++ + I ++ CAGY G
Sbjct: 141 WGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKPDEG 195
Query: 236 QR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+R D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 196 KRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGKGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 102 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 161
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 162 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 216
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 217 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 276
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 277 KKWIQKV 283
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 108 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 167
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 168 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 222
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 223 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 282
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 283 KKWIQKV 289
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 102 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 161
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 162 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 216
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 217 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 276
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 277 KKWIQKV 283
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 102 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 161
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 162 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 216
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 217 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 276
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 277 KKWIQKV 283
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 101 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 160
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 161 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 215
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 216 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 275
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 276 KKWIQKV 282
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 59/178 (33%), Positives = 93/178 (52%), Gaps = 20/178 (11%)
Query: 129 VRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT----GRVATVSG 183
+ ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + + G V+G
Sbjct: 111 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTG 170
Query: 184 WGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--NG 235
WG LK G G PSVLQ V +P++E VC++ + I ++ CAGY G
Sbjct: 171 WGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKPDEG 225
Query: 236 QR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+R D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 226 KRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 283
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 104 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 163
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 164 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 218
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 219 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 278
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 279 KKWIQKV 285
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKIGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 90/181 (49%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GD GGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDCGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCRDDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 90/181 (49%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G V G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVKWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 61/181 (33%), Positives = 97/181 (53%), Gaps = 19/181 (10%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA- 233
G V+GWG LK G PSVLQ V +P++E VC++ + I ++ CAGY
Sbjct: 132 AGYKGRVTGWGNLK---GQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKP 183
Query: 234 -NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
G+R D+CEGDSGGP +++ + W G VS G C G Y K W+Q
Sbjct: 184 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 243
Query: 291 I 291
+
Sbjct: 244 V 244
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 12/161 (7%)
Query: 131 RVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLK-Y 189
+VI+H Y++ +NDI L++L P + +S++ + +P +G VSGWG L
Sbjct: 69 KVIMHPSYNSRNLDNDIMLIKLSKPASLNSYVSTVALPSSCAS-SGTRCLVSGWGNLSGS 127
Query: 190 GGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLM 249
P L+ + +P++ ++ C + I ++ CAG+ G +DSC+GDSGGP++
Sbjct: 128 SSNYPDTLRCLDLPILSSSSCNSAY-----PGQITSNMFCAGFMEGGKDSCQGDSGGPVV 182
Query: 250 IEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
+ L G VS G CA PGVY + Y+ W+ +
Sbjct: 183 CNGQ-----LQGVVSWGYGCAQRNKPGVYTKVCNYRSWISS 218
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T N+I L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 97.8 bits (242), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 237 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 296
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 297 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 351
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 352 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 411
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 412 KKWIQKV 418
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 97.8 bits (242), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 58 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 115
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +L+ + P++ C+ A + I ++ +
Sbjct: 116 SCAP-AGTQCLISGWGNTLSSGVNEPDLLKCLDAPLLPQADCE-----ASYPGKITDNMV 169
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 170 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 224
Query: 289 Q 289
Q
Sbjct: 225 Q 225
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 97.8 bits (242), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 90/181 (49%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G V G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVEWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 97.8 bits (242), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 97.8 bits (242), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 59/178 (33%), Positives = 93/178 (52%), Gaps = 20/178 (11%)
Query: 129 VRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT----GRVATVSG 183
+ ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + + G V+G
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTG 140
Query: 184 WGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--NG 235
WG LK G G PSVLQ V +P++E VC++ + I ++ CAGY G
Sbjct: 141 WGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKPDEG 195
Query: 236 QR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+R D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 196 KRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 97.8 bits (242), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKFGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 97.8 bits (242), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 97.8 bits (242), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAG G +DSC+GDSGG
Sbjct: 125 KSSGTSXPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGXLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 97.8 bits (242), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 58 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 115
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 116 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 169
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+G+SGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 170 CVGFLEGGKDSCQGNSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 224
Query: 289 Q 289
Q
Sbjct: 225 Q 225
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 97.8 bits (242), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 59/178 (33%), Positives = 93/178 (52%), Gaps = 20/178 (11%)
Query: 129 VRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT----GRVATVSG 183
+ ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + + G V+G
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTG 140
Query: 184 WGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--NG 235
WG LK G G PSVLQ V +P++E VC++ + I ++ CAGY G
Sbjct: 141 WGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKPDEG 195
Query: 236 QR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+R D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 196 KRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 97.8 bits (242), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T N+I L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGDEQFV-NAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G +DSC+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 97.4 bits (241), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 61/181 (33%), Positives = 97/181 (53%), Gaps = 17/181 (9%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA- 233
G V+GWG LK G PSVLQ V +P++E VC++ + I ++ CAGY
Sbjct: 132 AGYKGRVTGWGNLKEKGQ-PSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKP 185
Query: 234 -NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
G+R D+CEGDSGGP +++ + W G VS G C G Y K W+Q
Sbjct: 186 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 245
Query: 291 I 291
+
Sbjct: 246 V 246
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 97.4 bits (241), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 61/187 (32%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 121 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 180
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 181 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 235
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGD+GGP +++ + W G VS G C G Y
Sbjct: 236 CAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 295
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 296 KKWIQKV 302
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 97.4 bits (241), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 57/167 (34%), Positives = 87/167 (52%), Gaps = 14/167 (8%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAY-DSHIVPICMPKDDDDFTGRVATVSGWGR 186
+ + IVH Y++ T NDI L++L++ + DS + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLXDSRVASISLPTSCAS-AGTQCLISGWGN 124
Query: 187 LKYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSG 245
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GDSG
Sbjct: 125 TKSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDSG 179
Query: 246 GPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
GP++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 GPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 221
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 97.4 bits (241), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 61/187 (32%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 103 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 162
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 163 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 217
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGD+GGP +++ + W G VS G C G Y
Sbjct: 218 CAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 277
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 278 KKWIQKV 284
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 97.4 bits (241), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 58/181 (32%), Positives = 90/181 (49%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G + SC+GDSGGP++ E L G VS G CA P PGVY + Y W+
Sbjct: 162 CVGFLEGGKSSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPGVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 61/181 (33%), Positives = 97/181 (53%), Gaps = 17/181 (9%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA- 233
G V+GWG LK G PSVLQ V +P++E VC++ + I ++ CAGY
Sbjct: 132 AGYKGRVTGWGNLKETGQ-PSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKP 185
Query: 234 -NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
G+R D+CEGDSGGP +++ + W G VS G C G Y K W+Q
Sbjct: 186 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 245
Query: 291 I 291
+
Sbjct: 246 V 246
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGPLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 61/181 (33%), Positives = 97/181 (53%), Gaps = 17/181 (9%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA- 233
G V+GWG LK G PSVLQ V +P++E VC++ + I ++ CAGY
Sbjct: 132 AGYKGRVTGWGNLKETGQ-PSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKP 185
Query: 234 -NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
G+R D+CEGDSGGP +++ + W G VS G C G Y K W+Q
Sbjct: 186 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 245
Query: 291 I 291
+
Sbjct: 246 V 246
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 61/187 (32%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 73 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 132
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 133 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 187
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGD+GGP +++ + W G VS G C G Y
Sbjct: 188 CAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 247
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 248 KKWIQKV 254
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 61/187 (32%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGD+GGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 61/187 (32%), Positives = 98/187 (52%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTTNVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+C+GDSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACQGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 58/188 (30%), Positives = 96/188 (51%), Gaps = 11/188 (5%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFEN--DIALLELETPIAYDSHIVPIC 166
V G + +S S++ V +++VH+ +++ N DIALL+L +P++ I C
Sbjct: 56 VLGRHSLS--TNEPGSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKIQLGC 113
Query: 167 MPKDDDDF-TGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN 225
+P V V+GWGRL+ G P +LQ+ Q+ V++ C + T+
Sbjct: 114 LPAAGTILPNNYVCYVTGWGRLQTNGASPDILQQGQLLVVDYATCSK---PGWWGSTVKT 170
Query: 226 SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHG--IKCAAPYLPGVYMRTTY 283
+ +CAG +G SC GDSGGPL + +G W + G VS G + C + P V+ R +
Sbjct: 171 NMICAG-GDGIISSCNGDSGGPLNCQGANGQWQVHGIVSFGSSLGCNYYHKPSVFTRVSN 229
Query: 284 YKPWLQTI 291
Y W+ ++
Sbjct: 230 YIDWINSV 237
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 58/178 (32%), Positives = 93/178 (52%), Gaps = 20/178 (11%)
Query: 129 VRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT----GRVATVSG 183
+ ++ +H +Y+ + +IAL++L+ P+A+ +I P+C+P + + G V+G
Sbjct: 81 LEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTG 140
Query: 184 WGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--NG 235
WG LK G G PSVLQ V +P++E VC++ + I ++ CAGY G
Sbjct: 141 WGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKPDEG 195
Query: 236 QR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+R D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 196 KRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 95.9 bits (237), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 61/187 (32%), Positives = 97/187 (51%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CE DSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEADSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 95.5 bits (236), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNKRRKNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 95.5 bits (236), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 56/178 (31%), Positives = 91/178 (51%), Gaps = 20/178 (11%)
Query: 129 VRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT----GRVATVSG 183
+ ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + + G V+G
Sbjct: 81 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTG 140
Query: 184 WGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA---N 234
WG LK G G PSVLQ V +P++E VC++ + I ++ CAG+
Sbjct: 141 WGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGFKVNDT 195
Query: 235 GQRDSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+ D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 196 KRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKKWIQKV 253
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 95.1 bits (235), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 58/178 (32%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 114 DISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDD 173
D + E E V VI H ++ T++ DIA+L L+TPI + ++ P +P
Sbjct: 56 DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPASLPTAPPA 115
Query: 174 FTGRVATVSGWGRLKYGGG-VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGY 232
TG +SGWG G P LQ + PV+ C+ A + I ++ C G+
Sbjct: 116 -TGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCE-----ASYPGKITSNMFCVGF 169
Query: 233 ANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
G +DSC+GDSGGP++ + L G VS G CA PGVY + Y W++
Sbjct: 170 LEGGKDSCQGDSGGPVVCNGQ-----LQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKN 222
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 95.1 bits (235), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 88/166 (53%), Gaps = 9/166 (5%)
Query: 129 VRRVIVH---RQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVATVSGW 184
+RRV VH RQ ++ FE DIALLELE + +++PIC+P +D + G + VSG+
Sbjct: 74 IRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDTFYDLGLMGYVSGF 133
Query: 185 GRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDS 244
G ++ + L+ V++PV C+ + + CAG+ + ++D+C+GDS
Sbjct: 134 GVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDS 191
Query: 245 GGPLMIERED-GHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
GG + + WV G VS GI C+ Y G Y + Y W++
Sbjct: 192 GGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVDWIK 235
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 94.7 bits (234), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 57/167 (34%), Positives = 89/167 (53%), Gaps = 11/167 (6%)
Query: 129 VRRVIVH---RQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDF--TGRVATVSG 183
+RRV VH RQ ++ FE DIALLELE + +++PIC+P D+D F G + VSG
Sbjct: 231 IRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLP-DNDTFYDLGLMGYVSG 289
Query: 184 WGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGD 243
+G ++ + L+ V++PV C+ + + CAG+ + ++D+C+GD
Sbjct: 290 FGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGD 347
Query: 244 SGGPLMIERED-GHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
SGG + + WV G VS GI C+ Y G Y + Y W++
Sbjct: 348 SGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVDWIK 392
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 94.7 bits (234), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 88/166 (53%), Gaps = 9/166 (5%)
Query: 129 VRRVIVH---RQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVATVSGW 184
+RRV VH RQ ++ FE DIALLELE + +++PIC+P +D + G + VSG+
Sbjct: 163 IRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDTFYDLGLMGYVSGF 222
Query: 185 GRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDS 244
G ++ + L+ V++PV C+ + + CAG+ + ++D+C+GDS
Sbjct: 223 GVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDS 280
Query: 245 GGPLMIERED-GHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
GG + + WV G VS GI C+ Y G Y + Y W++
Sbjct: 281 GGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVDWIK 324
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 94.7 bits (234), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 61/187 (32%), Positives = 97/187 (51%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CE DSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEPDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 94.7 bits (234), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 20/178 (11%)
Query: 129 VRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT----GRVATVSG 183
+ ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + + G V+G
Sbjct: 85 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTG 144
Query: 184 WGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--NG 235
WG LK G G PSVLQ V +P++E VC++ + I ++ CA Y G
Sbjct: 145 WGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAYYKPDEG 199
Query: 236 QR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+R D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 200 KRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 257
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 94.4 bits (233), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 54/164 (32%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
N ++I H QYD T NDI L++L + ++H+ I +P TG +SGWG
Sbjct: 66 NAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINAHVSTISLPTAPPA-TGTKCLISGWGNT 124
Query: 188 KYGGG-VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
G P LQ + PV+ C+ A + I ++ C G+ G +DSC+GD+GG
Sbjct: 125 ASSGADYPDELQCLDAPVLSQAKCE-----ASYPGKITSNMFCVGFLEGGKDSCQGDAGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
P++ + L G VS G CA PGVY + Y W++
Sbjct: 180 PVVCNGQ-----LQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKN 218
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 94.0 bits (232), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + ++ I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSRIITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 94.0 bits (232), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 57/181 (31%), Positives = 89/181 (49%), Gaps = 14/181 (7%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I+ LE N ++I H +D T NDI L++L +P+ ++ + + +P
Sbjct: 50 LGEHNIN-VLEGNEQFV-NAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 107
Query: 170 DDDDFTGRVATVSGWGR-LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G +SGWG L G P +LQ + P++ C+ A + I ++ +
Sbjct: 108 SCAP-AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-----ASYPGKITDNMV 161
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
C G+ G + SC+GDSGGP++ E L G VS G CA P P VY + Y W+
Sbjct: 162 CVGFLEGGKGSCQGDSGGPVVCNGE-----LQGIVSWGYGCALPDNPDVYTKVCNYVDWI 216
Query: 289 Q 289
Q
Sbjct: 217 Q 217
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 94.0 bits (232), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
N ++I H ++ T +NDI L++L +P +S + + +P+ + +SGWG
Sbjct: 69 NAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECSLISGWGNT 128
Query: 188 K-YGGGVPSVLQ-EVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSC-EGDS 244
K G PS+LQ ++ PV+ ++ C+ + I + +C G+ G +DSC +GDS
Sbjct: 129 KSSGSSYPSLLQCSLKAPVLSDSSCKSSY-----PGQITGNMICVGFLEGGKDSCSQGDS 183
Query: 245 GGPLMIEREDGHWVLAGTVSHGIKCAA-PYLPGVYMRTTYYKPWLQ 289
GGP++ L G VS G C+A PGVY + Y W+Q
Sbjct: 184 GGPVVCSNGQ----LQGIVSWGYGCSAQKNKPGVYTKVCNYVNWIQ 225
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 11/167 (6%)
Query: 129 VRRVIVH---RQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDF--TGRVATVSG 183
+RRV VH RQ ++ FE DIALLELE + +++PIC+P D+D F G + VSG
Sbjct: 163 IRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLP-DNDTFYDLGLMGYVSG 221
Query: 184 WGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGD 243
+G ++ + L+ V++PV C+ + + CAG+ + ++D+C+GD
Sbjct: 222 FGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGD 279
Query: 244 SGGPLMIERED-GHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
+GG + + WV G VS GI C+ Y G Y + Y W++
Sbjct: 280 AGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVDWIK 324
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSAIITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSYIITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 54/164 (32%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
N ++I H QYD T NDI L++L + ++ + I +P TG +SGWG
Sbjct: 66 NAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPP-ATGTKCLISGWGNT 124
Query: 188 KYGGG-VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
G P LQ + PV+ C+ A + I ++ C G+ G +DSC+GDSGG
Sbjct: 125 ASSGADXPDELQCLDAPVLSQAKCE-----ASYPGKITSNMFCVGFLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
P++ + L G VS G CA PGVY + Y W++
Sbjct: 180 PVVCNGQ-----LQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKN 218
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSWIITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 54/166 (32%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CA G+ DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAYGLEGKGDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G C A PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCQAKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 91.7 bits (226), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 54/166 (32%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +D+C+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 91.7 bits (226), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 96/187 (51%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLKYGGGV------PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG L+ PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+CEGDSGGP +++ + W G VS G C G Y
Sbjct: 187 CAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 53/163 (32%), Positives = 81/163 (49%), Gaps = 12/163 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGR- 186
N ++I H +Y+ T +NDI L++L +P ++ + I +P G +SGWG
Sbjct: 66 NAVKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPPA-AGTECLISGWGNT 124
Query: 187 LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
L +G P L+ + PV+ C+ A + I NS C G+ G +DSC+ DSGG
Sbjct: 125 LSFGADYPDELKCLDAPVLTQAECK-----ASYPGKITNSMFCVGFLEGGKDSCQRDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
P++ + L G VS G CA PGVY + Y W++
Sbjct: 180 PVVCNGQ-----LQGVVSWGHGCAWKNRPGVYTKVYNYVDWIK 217
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 91.3 bits (225), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +D+C+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PG+Y + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGIYTKVCNYVSWIKQTI 220
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 91.3 bits (225), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 60/187 (32%), Positives = 96/187 (51%), Gaps = 22/187 (11%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK------YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G V+GWG LK G G PSVLQ V +P++E VC++ + I ++
Sbjct: 132 AGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMF 186
Query: 229 CAGYA--NGQR-DSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
CAGY G+R D+ EGDSGGP +++ + W G VS G G Y
Sbjct: 187 CAGYKPDEGKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEGADRDGKYGFYTHVFRL 246
Query: 285 KPWLQTI 291
K W+Q +
Sbjct: 247 KKWIQKV 253
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 91.3 bits (225), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +D+C+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PG+Y + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGIYTKVCNYVSWIKQTI 220
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 91.3 bits (225), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 58/168 (34%), Positives = 82/168 (48%), Gaps = 12/168 (7%)
Query: 125 ISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDD-FTGRVATVSG 183
I+ ++ V VH Y ND+A+L+L T I +I + D G ATV+G
Sbjct: 65 ITSSLSSVRVHPSYSGN--NNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVAG 122
Query: 184 WGRLKYGGG-VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEG 242
WG GG P L +V VP++ C+ + T+ I N CAG ++G +DSC+G
Sbjct: 123 WGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTS----AITNQMFCAGVSSGGKDSCQG 178
Query: 243 DSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
DSGGP++ D L G VS G CA P GVY + ++ T
Sbjct: 179 DSGGPIV----DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFIDT 222
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 91.3 bits (225), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 54/166 (32%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +D+C+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 91.3 bits (225), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 54/166 (32%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDSCQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PG Y + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTI 220
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 91.3 bits (225), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 58/168 (34%), Positives = 82/168 (48%), Gaps = 12/168 (7%)
Query: 125 ISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDD-FTGRVATVSG 183
I+ ++ V VH Y ND+A+L+L T I +I + D G ATV+G
Sbjct: 65 ITSSLSSVRVHPSYSGN--NNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVAG 122
Query: 184 WGRLKYGGG-VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEG 242
WG GG P L +V VP++ C+ + T+ I N CAG ++G +DSC+G
Sbjct: 123 WGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTS----AITNQMFCAGVSSGGKDSCQG 178
Query: 243 DSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
DSGGP++ D L G VS G CA P GVY + ++ T
Sbjct: 179 DSGGPIV----DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFIDT 222
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 90.9 bits (224), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 12/163 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGR- 186
N ++I H +Y+ T +NDI L++L +P ++ + I +P G +SGWG
Sbjct: 66 NAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPPA-AGTECLISGWGNT 124
Query: 187 LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
L +G P L+ + PV+ C+ A + I NS C G+ G +DSC+ D+GG
Sbjct: 125 LSFGADYPDELKCLDAPVLTQAECK-----ASYPGKITNSMFCVGFLEGGKDSCQRDAGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
P++ + L G VS G CA PGVY + Y W++
Sbjct: 180 PVVCNGQ-----LQGVVSWGHGCAWKNRPGVYTKVYNYVDWIK 217
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 90.9 bits (224), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 12/163 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGR- 186
N ++I H +Y+ T +NDI L++L +P ++ + I +P G +SGWG
Sbjct: 66 NAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPPA-AGTECLISGWGNT 124
Query: 187 LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
L +G P L+ + PV+ C+ A + I NS C G+ G +DSC+ D+GG
Sbjct: 125 LSFGADYPDELKCLDAPVLTQAECK-----ASYPGKITNSMFCVGFLEGGKDSCQRDAGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
P++ + L G VS G CA PGVY + Y W++
Sbjct: 180 PVVCNGQ-----LQGVVSWGHGCAWKNRPGVYTKVYNYVDWIK 217
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 90.9 bits (224), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +D+C+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PG+Y + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGEGCAQKNKPGIYTKVCNYVSWIKQTI 220
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 90.5 bits (223), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +D+C+GD+GG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 62/179 (34%), Positives = 89/179 (49%), Gaps = 12/179 (6%)
Query: 120 EAKRSISKNVRRVIVHRQYDAATFENDIALLELETP-IAYDSHI---VPICMPKDDDDFT 175
+ KR + + V R+I H Y+A T++NDIAL+E++ D + +P C+P F
Sbjct: 385 DLKRIVIEYVDRIIFHENYNAGTYQNDIALIEMKKDGNKKDCELPRSIPACVPWSPYLFQ 444
Query: 176 -GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYAN 234
VSGWGR K V S LQ +V +I N C + + + K + CAG +
Sbjct: 445 PNDTCIVSGWGREKDNERVFS-LQWGEVKLISN--CSKFYGNRFYEKEM----ECAGTYD 497
Query: 235 GQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTITG 293
G D+C+GDSGGPL+ + + G VS G C P PGVY + Y W+ G
Sbjct: 498 GSIDACKGDSGGPLVCMDANNVTYVWGVVSWGENCGKPEFPGVYTKVANYFDWISYHVG 556
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 60/190 (31%), Positives = 88/190 (46%), Gaps = 16/190 (8%)
Query: 106 LVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDA--ATFENDIALLELETPIAYDSHIV 163
+ ++ + D SG A NV +H Y A A++ NDIA+L L T I+ +I
Sbjct: 57 IAGLWQQSDTSGTQTA------NVDSYTMHENYGAGTASYSNDIAILHLATSISLGGNIQ 110
Query: 164 PICMP-KDDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKT 222
+P +++D+ G +SGWGR +P +LQ+ +PVI C G A
Sbjct: 111 AAVLPANNNNDYAGTTCVISGWGRTDGTNNLPDILQKSSIPVITTAQCTAAMVGVGGAN- 169
Query: 223 IINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAG----TVSHGIKCAAPYLPGVY 278
I ++ +C G +C GDSGGPL DG + G VS G+ P P VY
Sbjct: 170 IWDNHICVQDPAGNTGACNGDSGGPL--NCPDGGTRVVGVTSWVVSSGLGACLPDYPSVY 227
Query: 279 MRTTYYKPWL 288
R + Y W+
Sbjct: 228 TRVSAYLGWI 237
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 90.1 bits (222), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +D+C+GD+GG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 90.1 bits (222), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 53/166 (31%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +D+C+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PG Y + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTI 220
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 53/166 (31%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +D+C+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PG Y + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKLCNYVSWIKQTI 220
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 57/168 (33%), Positives = 81/168 (48%), Gaps = 12/168 (7%)
Query: 125 ISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDD-FTGRVATVSG 183
I+ ++ V VH Y ND+A+L+L T I +I + D G ATV+G
Sbjct: 65 ITSSLSSVRVHPSYSGN--NNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVAG 122
Query: 184 WGRLKYGGG-VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEG 242
WG GG P L +V VP++ C+ + T+ I N CAG ++G +DSC+G
Sbjct: 123 WGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTS----AITNQMFCAGVSSGGKDSCQG 178
Query: 243 DSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
D GGP++ D L G VS G CA P GVY + ++ T
Sbjct: 179 DXGGPIV----DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFIDT 222
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +D+C+GD+GG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PG Y + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTI 220
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 88.2 bits (217), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ CAGY G +D+C+GD+GG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PG Y + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTI 220
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 88.2 bits (217), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 57/179 (31%), Positives = 87/179 (48%), Gaps = 22/179 (12%)
Query: 129 VRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-----GRVATVS 182
+ ++ VH +Y+ + DIALL+L+ P+ + +I P+C+P D T G V+
Sbjct: 81 LEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLP-DKQTVTSLLRAGYKGRVT 139
Query: 183 GWGRLKYGGGV------PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--- 233
GWG L+ PSVLQ V +P++E VC+ A I ++ CAG+
Sbjct: 140 GWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCK-----ASTRIRITDNMFCAGFKVND 194
Query: 234 NGQRDSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+ D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 195 TKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRKGKYGFYTHVFRLKRWIQKV 253
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 88.2 bits (217), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 16/166 (9%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ ++ C+ + I ++ CAG G DSC+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILSDSSCKSAY-----PGQITSNMFCAGLEGG--DSCQGDSGG 177
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PGVY + Y W+ QTI
Sbjct: 178 PVVCSGK-----LQGIVSWGSGCAKNK-PGVYTKVCNYVSWIKQTI 217
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 87.8 bits (216), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 57/174 (32%), Positives = 86/174 (49%), Gaps = 11/174 (6%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP 168
+ G + I+ E K+ + V++ + YD AT E D+ LL+L + ++ + +P
Sbjct: 51 ILGAHSITREEPTKQIML--VKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLP 108
Query: 169 KDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSF 227
K DD G + V+GWGR L+EV++ +I+ VC + + +N
Sbjct: 109 KKGDDVKPGTMCQVAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHYNFNPVIGMN-M 167
Query: 228 LCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGI--KCAAPYLPGVYM 279
+CAG G RDSC GDSG PL+ E V G S G+ KC P PGVY+
Sbjct: 168 VCAGSLRGGRDSCNGDSGSPLLCEG-----VFRGVTSFGLENKCGDPRGPGVYI 216
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 87.8 bits (216), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 57/179 (31%), Positives = 87/179 (48%), Gaps = 22/179 (12%)
Query: 129 VRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-----GRVATVS 182
+ ++ VH +Y+ + DIALL+L+ P+ + +I P+C+P D T G V+
Sbjct: 81 LEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLP-DKQTVTSLLRAGYKGRVT 139
Query: 183 GWGRLKYGGGV------PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--- 233
GWG L+ PSVLQ V +P++E VC+ A I ++ CAG+
Sbjct: 140 GWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCK-----ASTRIRITDNMFCAGFKVND 194
Query: 234 NGQRDSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+ D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 195 TKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKAWIQKV 253
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 87.8 bits (216), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + +S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ C GY G +D+C+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCVGYLEGGKDACQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PG Y + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTI 220
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 87.4 bits (215), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP 168
+ G + I+ E K+ + V++ + YD AT E D+ LL+L + ++ + +P
Sbjct: 51 ILGAHSITREEPTKQIML--VKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLP 108
Query: 169 KDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSF 227
K DD G + V+GWGR L+EV + +I+ VC + + +N
Sbjct: 109 KKGDDVKPGTMCQVAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYNFNPVIGMN-M 167
Query: 228 LCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGI--KCAAPYLPGVYM 279
+CAG G RDSC GDSG PL+ E V G S G+ KC P PGVY+
Sbjct: 168 VCAGSLRGGRDSCNGDSGSPLLCEG-----VFRGVTSFGLENKCGDPRGPGVYI 216
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 87.4 bits (215), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 60/179 (33%), Positives = 87/179 (48%), Gaps = 26/179 (14%)
Query: 131 RVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDD-------DFTGRVATVS 182
++ +H +Y+ + DIALL+L+ PI +I P+C+P F GR V+
Sbjct: 132 KIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGR---VT 188
Query: 183 GWG--RLKYGGGV----PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQ 236
GWG R + V PSVLQ V +P++E VC+ A I ++ CAGY G+
Sbjct: 189 GWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCK-----ASTRIRITDNMFCAGYKPGE 243
Query: 237 ---RDSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 244 GKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 302
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 87/185 (47%), Gaps = 14/185 (7%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP 168
+ G + +S +KR +V R + H Y T ++D+ LL+L + P+
Sbjct: 54 LLGAHSLSQPEPSKRLY--DVLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVRPLPWQ 111
Query: 169 KDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSF 227
+ D D G + V+GWG + + G P LQ V +PV++ C H I
Sbjct: 112 RVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTH---HDGAITERL 168
Query: 228 LCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYMRTTYYKP 286
+CA + +RDSC+GDSGGPL+ VL G VS G + C PG+Y R Y
Sbjct: 169 MCA--ESNRRDSCKGDSGGPLVCGG-----VLEGVVSWGSRVCGNRKKPGIYTRVASYAA 221
Query: 287 WLQTI 291
W+ ++
Sbjct: 222 WIDSV 226
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+V +V++ YD ND+AL+ L PI ++ + PI + +D+D T++GWG
Sbjct: 69 DVEDAVVNKNYDDFLLRNDVALVHLTNPIKFNDLVQPIKLSTNDEDLESNPCTLTGWGST 128
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
+ GG P+ LQE+++ V C+ +I+S +C G+ +C GDSGGP
Sbjct: 129 RLGGNTPNALQEIELIVHPQKQCER------DQWRVIDSHICTLTKRGE-GACHGDSGGP 181
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
L+ + G VS G CA P VY R + + W+
Sbjct: 182 LV-----ANGAQIGIVSFGSPCALGE-PDVYTRVSSFVSWIN 217
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 86.7 bits (213), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 63/176 (35%), Positives = 95/176 (53%), Gaps = 22/176 (12%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETP---IAYDSHIV-PICMPKDD---DDFTGRVATV 181
V++ IVH+++D T+ NDIALL+L++ A +S V IC+P+ + D+T +
Sbjct: 92 VKKYIVHKEFDDDTYNNDIALLQLKSDSPQCAQESDSVRAICLPEANLQLPDWT--ECEL 149
Query: 182 SGWGRLKYGGGVPS-VLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAG-------YA 233
SG+G+ K S L+E V + ++ C F KT+ N+ LCAG Y
Sbjct: 150 SGYGKHKSSSPFYSEQLKEGHVRLYPSSRCAPKFL---FNKTVTNNMLCAGDTRSGEIYP 206
Query: 234 NGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
N D+C+GDSGGPL+ D H L G +S G+ C +PGVY + T Y W++
Sbjct: 207 N-VHDACQGDSGGPLVC-MNDNHMTLLGIISWGVGCGEKDVPGVYTKVTNYLGWIR 260
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 86.7 bits (213), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 60/179 (33%), Positives = 87/179 (48%), Gaps = 26/179 (14%)
Query: 131 RVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDD-------DFTGRVATVS 182
++ +H +Y+ + DIALL+L+ PI +I P+C+P F GR V+
Sbjct: 83 KIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGR---VT 139
Query: 183 GWG--RLKYGGGV----PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQ 236
GWG R + V PSVLQ V +P++E VC+ A I ++ CAGY G+
Sbjct: 140 GWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCK-----ASTRIRITDNMFCAGYKPGE 194
Query: 237 ---RDSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 195 GKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 86.7 bits (213), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 60/179 (33%), Positives = 87/179 (48%), Gaps = 26/179 (14%)
Query: 131 RVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDD-------DFTGRVATVS 182
++ +H +Y+ + DIALL+L+ PI +I P+C+P F GR V+
Sbjct: 83 KIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGR---VT 139
Query: 183 GWG--RLKYGGGV----PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQ 236
GWG R + V PSVLQ V +P++E VC+ A I ++ CAGY G+
Sbjct: 140 GWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCK-----ASTRIRITDNMFCAGYKPGE 194
Query: 237 ---RDSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
D+CEGDSGGP +++ + W G VS G C G Y K W+Q +
Sbjct: 195 GKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 253
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
+ + IVH Y++ T+ NDI L++L++ + S + I +P G +SGWG
Sbjct: 66 SASKSIVHPSYNSETYNNDIMLIKLKSAASLXSRVASISLPTSCAS-AGTQCLISGWGNT 124
Query: 188 KYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
K G P VL+ ++ P++ + + + I ++ C GY G +D+C+GDSGG
Sbjct: 125 KSSGTSYPDVLKCLKAPILS-----DSSCKSASSFIITSNMFCVGYLEGGKDACQGDSGG 179
Query: 247 PLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL-QTI 291
P++ + L G VS G CA PG Y + Y W+ QTI
Sbjct: 180 PVVCSGK-----LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTI 220
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 86.3 bits (212), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 56/179 (31%), Positives = 87/179 (48%), Gaps = 22/179 (12%)
Query: 129 VRRVIVHRQYDA-ATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-----GRVATVS 182
+ ++ VH +Y+ + DIALL+L+ P+ + +I P+C+P D T G V+
Sbjct: 81 LEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLP-DKQTVTSLLRAGYKGRVT 139
Query: 183 GWGRLKYGGGV------PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--- 233
GWG L+ PSVLQ V +P++E VC+ A I ++ CAG+
Sbjct: 140 GWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCK-----ASTRIRITDNMFCAGFKVND 194
Query: 234 NGQRDSCEGDSGGPLMIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+ D+CEGD+GGP +++ + W G VS G C G Y K W+Q +
Sbjct: 195 TKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKRWIQKV 253
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 86.3 bits (212), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 7/169 (4%)
Query: 124 SISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRV-ATVS 182
S+ V + VH++++A NDIAL++L + I C+P+ D V+
Sbjct: 70 SLFVGVDTIHVHKRWNALLLRNDIALIKLAEHVELSDTIQVACLPEKDSLLPKDYPCYVT 129
Query: 183 GWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEG 242
GWGRL G + LQ+ PV+++ C + K + +CAG +G +C G
Sbjct: 130 GWGRLWTNGPIADKLQQGLQPVVDHATCSRIDWWGFRVK---KTMVCAG-GDGVISACNG 185
Query: 243 DSGGPLMIEREDGHWVLAGTVSHGIK--CAAPYLPGVYMRTTYYKPWLQ 289
DSGGPL + E+G W + G VS G + C P VY R + Y W+
Sbjct: 186 DSGGPLNCQLENGSWEVFGIVSFGSRRGCNTRKKPVVYTRVSAYIDWIN 234
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 27/199 (13%)
Query: 110 FGEYDISGELEAKRS----------ISKNVRRVIVHRQYDAATFENDIALLELETPIAYD 159
GE+ IS E + ++ ++ + + ++H +YDA +DIALL+L + +
Sbjct: 177 LGEHRISTEEDCRQQGRKKKCAPPVVNVGIEKHLIHEKYDARHIMHDIALLKLNRSVPFQ 236
Query: 160 SHIVPICMPKDDD--DFTGRVAT--VSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQ 215
HI PIC+P D+ + +++T V+GWG + G VL + VP+ + C + ++
Sbjct: 237 KHIKPICLPITDELKEKAEQISTYFVTGWGTTE-NGSSSDVLLQANVPLQPRSACSQAYR 295
Query: 216 TAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIERED-GHW----VLAGTVSHG-IKC 269
A + S LC G + Q DSC+GDSGGPL + G + V G VS G + C
Sbjct: 296 RA-----VPLSQLCVGGGDLQ-DSCKGDSGGPLQAPAQYLGEYAPKMVEFGIVSQGVVTC 349
Query: 270 AAPYLPGVYMRTTYYKPWL 288
LPG+Y Y W+
Sbjct: 350 GQISLPGLYTNVGEYVQWI 368
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 57/181 (31%), Positives = 84/181 (46%), Gaps = 15/181 (8%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE+ I ++ IS + VI H Y + NDI L++L P + ++ + +P
Sbjct: 50 LGEHHIRVNEGTEQYISSS--SVIRHPNYSSYNINNDIMLIKLTKPATLNQYVHAVALPT 107
Query: 170 D-DDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
+ D T + TVSGWG LQ + +P++ + C + I S
Sbjct: 108 ECAADAT--MCTVSGWGNTMSSVADGDKLQCLSLPILSHADCANSY-----PGMITQSMF 160
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
CAGY G +DSC+GDSGGP++ VL G VS G CA PGVY + W+
Sbjct: 161 CAGYLEGGKDSCQGDSGGPVVCNG-----VLQGVVSWGYGCAERDHPGVYAKVCVLSGWV 215
Query: 289 Q 289
+
Sbjct: 216 R 216
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP 168
+ G + +S +KR +V R + H T ++D+ LL+L + P+
Sbjct: 61 LLGAHSLSQPEPSKRLY--DVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQ 118
Query: 169 KDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSF 227
+ D D G + V+GWG + + G P LQ V +PV++ C H I
Sbjct: 119 RVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTH---HDGAITERL 175
Query: 228 LCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYMRTTYYKP 286
+CA + +RDSC+GDSGGPL+ VL G V+ G + C PG+Y R Y
Sbjct: 176 MCA--ESNRRDSCKGDSGGPLVCGG-----VLEGVVTSGSRVCGNRKKPGIYTRVASYAA 228
Query: 287 WLQTI 291
W+ ++
Sbjct: 229 WIDSV 233
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP 168
+ G + +S +KR +V R + H T ++D+ LL+L + P+
Sbjct: 54 LLGAHSLSQPEPSKRLY--DVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQ 111
Query: 169 KDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSF 227
+ D D G + V+GWG + + G P LQ V +PV++ C H I
Sbjct: 112 RVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTH---HDGAITERL 168
Query: 228 LCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYMRTTYYKP 286
+CA + +RDSC+GDSGGPL+ VL G V+ G + C PG+Y R Y
Sbjct: 169 MCA--ESNRRDSCKGDSGGPLVCGG-----VLEGVVTSGSRVCGNRKKPGIYTRVASYAA 221
Query: 287 WLQTI 291
W+ ++
Sbjct: 222 WIDSV 226
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 57/186 (30%), Positives = 84/186 (45%), Gaps = 15/186 (8%)
Query: 105 NLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVP 164
NL G++++ ++ S V R ++H YDAA+ + DI LL L P I P
Sbjct: 46 NLQVFLGKHNLRQRESSQEQSS--VVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP 103
Query: 165 ICMPKDDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTII 224
+ + +D T + GWG+ G P +Q + ++ C+ + I
Sbjct: 104 LPLERDCSANT-TSCHILGWGKTA-DGDFPDTIQCAYIHLVSREECEHAY-----PGQIT 156
Query: 225 NSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTY 283
+ LCAG +DSC+GDSGGPL+ L G VS G I C + PGVY
Sbjct: 157 QNMLCAGDEKYGKDSCQGDSGGPLVCGDH-----LRGLVSWGNIPCGSKEKPGVYTNVCR 211
Query: 284 YKPWLQ 289
Y W+Q
Sbjct: 212 YTNWIQ 217
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 55/185 (29%), Positives = 85/185 (45%), Gaps = 14/185 (7%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP 168
+ G + +S +KR +V R + H T ++D+ LL+L + P+
Sbjct: 54 LLGAHSLSQPEPSKRLY--DVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQ 111
Query: 169 KDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSF 227
+ D D G + V+GWG + + G P LQ V +PV++ C H I
Sbjct: 112 RVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTH---HDGAITERL 168
Query: 228 LCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYMRTTYYKP 286
+CA + +RDSC+GDSGGPL+ VL G V+ G C PG+Y R Y
Sbjct: 169 MCA--ESNRRDSCKGDSGGPLVCGG-----VLEGVVTSGSAVCGNRKKPGIYTRVASYAA 221
Query: 287 WLQTI 291
W+ ++
Sbjct: 222 WIDSV 226
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 54/185 (29%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP 168
+ G + +S +KR +V R + H T ++D+ LL+L + P+
Sbjct: 54 LLGAHSLSQPEPSKRLY--DVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQ 111
Query: 169 KDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSF 227
+ D D G + V+GWG + + G P LQ V +PV++ C H I
Sbjct: 112 RVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTH---HDGAITERL 168
Query: 228 LCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYMRTTYYKP 286
+CA + +RDSC+GD+GGPL+ VL G V+ G + C PG+Y R Y
Sbjct: 169 MCA--ESNRRDSCKGDAGGPLVCGG-----VLEGVVTSGSRVCGNRKKPGIYTRVASYAA 221
Query: 287 WLQTI 291
W+ ++
Sbjct: 222 WIDSV 226
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP 168
+ G + +S +KR +V R + H T ++D+ LL+L + P+
Sbjct: 54 LLGAHSLSQPEPSKRLY--DVLRAVPHPDSRPDTIDHDLLLLQLSEKATLGPAVRPLPWQ 111
Query: 169 KDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSF 227
+ D D G + V+GWG + + G P LQ V +PV++ C H I
Sbjct: 112 RVDRDVEPGTLCDVAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTH---HDGAITQRM 168
Query: 228 LCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYMRTTYYKP 286
+CA + +RDSC+GDSGGPL+ VL G V+ G + C PG+Y R Y
Sbjct: 169 MCA--ESNRRDSCKGDSGGPLVCGG-----VLEGVVTSGSRVCGNRKKPGIYTRVASYAA 221
Query: 287 WLQTI 291
W+ ++
Sbjct: 222 WIDSV 226
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 52/187 (27%), Positives = 95/187 (50%), Gaps = 15/187 (8%)
Query: 104 ANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIV 163
+++ G ++I + ++ I V+R I H Y+ F NDI LL+LE + + +
Sbjct: 48 SSINVTLGAHNIKEQERTQQFIP--VKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTAVR 105
Query: 164 PICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKT 222
P+ +P G++ +V+GWG + + + LQEV + V ++ C+ +F H
Sbjct: 106 PLRLPSSKAQVKPGQLCSVAGWGYVSM-STLATTLQEVLLTVQKDCQCERLF----HGNY 160
Query: 223 IINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTT 282
+ +C G + +GDSGGPL+ + V G +S+G K P PGVY++ +
Sbjct: 161 SRATEICVGDPKKTQTGFKGDSGGPLVCKD-----VAQGILSYGNKKGTP--PGVYIKVS 213
Query: 283 YYKPWLQ 289
++ PW++
Sbjct: 214 HFLPWIK 220
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 81.3 bits (199), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 63/191 (32%), Positives = 100/191 (52%), Gaps = 28/191 (14%)
Query: 115 ISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETP---IAYDSHIV-PICMPKD 170
+ GE E K + K IVH+++D T++NDIALL+L++ A +S +V +C+P
Sbjct: 82 VPGEEEQKFEVEK----YIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPA 137
Query: 171 D---DDFTGRVATVSGWGRLKYGGGVPS-VLQEVQVPVIENNVCQEMFQTAGHA--KTII 224
D D+T +SG+G+ + S L+E V + ++ C T+ H +T+
Sbjct: 138 DLQLPDWT--ECELSGYGKHEALSPFYSERLKEAHVRLYPSSRC-----TSQHLLNRTVT 190
Query: 225 NSFLCAGYANGQ------RDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVY 278
++ LCAG D+C+GDSGGPL+ DG L G +S G+ C +PGVY
Sbjct: 191 DNMLCAGDTRSGGPQANLHDACQGDSGGPLVC-LNDGRMTLVGIISWGLGCGQKDVPGVY 249
Query: 279 MRTTYYKPWLQ 289
+ T Y W++
Sbjct: 250 TKVTNYLDWIR 260
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 81.3 bits (199), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 143 FENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLKY-GGGVPSVLQEVQ 201
++ DI L+ L P+ +HI P+ +P + G V + GWG + +P V
Sbjct: 82 WDKDIMLIRLNRPVRNSAHIAPLSLPSNPPS-VGSVCRIMGWGTITSPNATLPDVPHCAN 140
Query: 202 VPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAG 261
+ +++ VCQ + K + + LCAG G +D+C+GDSGGPL+ + G
Sbjct: 141 INILDYAVCQAAY------KGLAATTLCAGILEGGKDTCKGDSGGPLICNGQ-----FQG 189
Query: 262 TVS-HGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+S G CA P PG+Y + Y W+Q+I
Sbjct: 190 ILSVGGNPCAQPRKPGIYTKVFDYTDWIQSI 220
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 81.3 bits (199), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 10/168 (5%)
Query: 118 ELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGR 177
+L++ ++ +V+ + T+ D AL++L PI + + + FT
Sbjct: 61 DLQSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQPINQPTLKIATTTAYNQGTFT-- 118
Query: 178 VATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYAN-GQ 236
V+GWG + GG L + VP + + C+ ++ + N +CAGY + G
Sbjct: 119 ---VAGWGANREGGSQQRYLLKANVPFVSDAACR----SSSSFILVANEMICAGYPDTGG 171
Query: 237 RDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
D+C+GDSGGP+ + W+ G VS G CA P PGVY + +
Sbjct: 172 VDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTF 219
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 80.9 bits (198), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 56/188 (29%), Positives = 94/188 (50%), Gaps = 16/188 (8%)
Query: 104 ANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIV 163
+N+ G ++I ++ I+ RR I H QY+ T +NDI LL+L + + ++
Sbjct: 48 SNINVTLGAHNIQRRENTQQHIT--ARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVN 105
Query: 164 PICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKT 222
P+ +P+ + G + TV+GWGR+ G L+EVQ+ V + C +F + +
Sbjct: 106 PVALPRAQEGLRPGTLCTVAGWGRVSMRRGT-DTLREVQLRVQRDRQCLRIFGSYDPRRQ 164
Query: 223 IINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTT 282
I C G ++ + +GDSGGPL+ V G VS+G P P V+ R +
Sbjct: 165 I-----CVGDRRERKAAFKGDSGGPLLCNN-----VAHGIVSYGKSSGVP--PEVFTRVS 212
Query: 283 YYKPWLQT 290
+ PW++T
Sbjct: 213 SFLPWIRT 220
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 63/191 (32%), Positives = 100/191 (52%), Gaps = 28/191 (14%)
Query: 115 ISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETP---IAYDSHIV-PICMPKD 170
+ GE E K + K IVH+++D T++NDIALL+L++ A +S +V +C+P
Sbjct: 69 VPGEEEQKFEVEK----YIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPA 124
Query: 171 D---DDFTGRVATVSGWGRLKYGGGVPS-VLQEVQVPVIENNVCQEMFQTAGHA--KTII 224
D D+T +SG+G+ + S L+E V + ++ C T+ H +T+
Sbjct: 125 DLQLPDWT--ECELSGYGKHEALSPFYSERLKEAHVRLYPSSRC-----TSQHLLNRTVT 177
Query: 225 NSFLCAGYANGQ------RDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVY 278
++ LCAG D+C+GDSGGPL+ DG L G +S G+ C +PGVY
Sbjct: 178 DNMLCAGDTRSGGPQANLHDACQGDSGGPLVC-LNDGRMTLVGIISWGLGCGQKDVPGVY 236
Query: 279 MRTTYYKPWLQ 289
+ T Y W++
Sbjct: 237 TKVTNYLDWIR 247
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 80.5 bits (197), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 56/188 (29%), Positives = 94/188 (50%), Gaps = 16/188 (8%)
Query: 104 ANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIV 163
+N+ G ++I ++ I+ RR I H QY+ T +NDI LL+L + + ++
Sbjct: 48 SNINVTLGAHNIQRRENTQQHIT--ARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVN 105
Query: 164 PICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKT 222
P+ +P+ + G + TV+GWGR+ G L+EVQ+ V + C +F + +
Sbjct: 106 PVALPRAQEGLRPGTLCTVAGWGRVSMRRGT-DTLREVQLRVQRDRQCLRIFGSYDPRRQ 164
Query: 223 IINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTT 282
I C G ++ + +GDSGGPL+ V G VS+G P P V+ R +
Sbjct: 165 I-----CVGDRRERKAAFKGDSGGPLLCNN-----VAHGIVSYGKSSGVP--PEVFTRVS 212
Query: 283 YYKPWLQT 290
+ PW++T
Sbjct: 213 SFLPWIRT 220
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 59/173 (34%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + IC+P +D F G
Sbjct: 101 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQF-GTSCE 159
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 160 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 216
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 217 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 268
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 57/186 (30%), Positives = 89/186 (47%), Gaps = 15/186 (8%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
G+ ++ E EA S+ V + VH ++++ NDIAL++L + I C+P
Sbjct: 70 LGKNNLEVEDEAG-SLYVGVDTIFVHEKWNSFLVRNDIALIKLAETVELGDTIQVACLPS 128
Query: 170 DDD----DFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN 225
+ D+ V+GWGRL G + + LQ+ PV++ C Q T+
Sbjct: 129 EGSLLPQDYP---CFVTGWGRLYTNGPIAAELQQGLQPVVDYATCS---QRDWWGTTVKE 182
Query: 226 SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVS--HGIKCAAPYLPGVYMRTTY 283
+ +CAG +G +C GDSGGPL + DG W + G VS G+ C P V+ R +
Sbjct: 183 TMVCAG-GDGVISACNGDSGGPLNCQ-ADGQWDVRGIVSFGSGLSCNTFKKPTVFTRVSA 240
Query: 284 YKPWLQ 289
Y W+
Sbjct: 241 YIDWIN 246
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 51/187 (27%), Positives = 95/187 (50%), Gaps = 15/187 (8%)
Query: 104 ANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIV 163
+++ G ++I + ++ I V+R I H Y+ F N+I LL+LE + + +
Sbjct: 48 SSINVTLGAHNIKEQERTQQFIP--VKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVR 105
Query: 164 PICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKT 222
P+ +P G++ +V+GWG + + + LQEV + V ++ C+ +F H
Sbjct: 106 PLRLPSSKAQVKPGQLCSVAGWGYVSM-STLATTLQEVLLTVQKDCQCERLF----HGNY 160
Query: 223 IINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTT 282
+ +C G + +GDSGGPL+ + V G +S+G K P PGVY++ +
Sbjct: 161 SRATEICVGDPKKTQTGFKGDSGGPLVCKD-----VAQGILSYGNKKGTP--PGVYIKVS 213
Query: 283 YYKPWLQ 289
++ PW++
Sbjct: 214 HFLPWIK 220
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 59/173 (34%), Positives = 88/173 (50%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + IC+P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKEQSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 10/184 (5%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP 168
V G + +S +K+++ +++ I + + NDI L++L+T + H+ + +
Sbjct: 57 VLGAHSLSKNEASKQTL--EIKKFIPFSRVTSDPQSNDIMLVKLQTAAKLNKHVKMLHIR 114
Query: 169 KDDDDFTGRVATVSGWGRLKYGGGVPS-VLQEVQVPVIENNVCQEMFQTAGHAKTIINSF 227
+G V+GWG PS L+EV V V+ +C G I
Sbjct: 115 SKTSLRSGTKCKVTGWGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGDP-FITKDM 173
Query: 228 LCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVY-MRTTYYKP 286
+CAG A GQ+DSC+GD+GGPL+ + V VS G +C PG+Y + T Y+
Sbjct: 174 VCAGDAKGQKDSCKGDAGGPLICKG-----VFHAIVSGGHECGVATKPGIYTLLTKKYQT 228
Query: 287 WLQT 290
W+++
Sbjct: 229 WIKS 232
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 56/186 (30%), Positives = 83/186 (44%), Gaps = 15/186 (8%)
Query: 105 NLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVP 164
NL G++++ + +V R ++H YDAA+ + DI LL L P I P
Sbjct: 47 NLQVFLGKHNL--RQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP 104
Query: 165 ICMPKDDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTII 224
+ + +D T + GWG+ G P +Q + ++ C+ + I
Sbjct: 105 LPLERDCSAQT-TSCHILGWGKTA-DGDFPDTIQCAYIHLVSREECEHAY-----PGQIT 157
Query: 225 NSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTY 283
+ LCAG +DSC+GDSGGPL+ L G VS G I C + PGVY
Sbjct: 158 QNMLCAGDEKYGKDSCQGDSGGPLVCGDH-----LRGLVSWGNIPCGSKEKPGVYTNVCR 212
Query: 284 YKPWLQ 289
Y W+Q
Sbjct: 213 YTNWIQ 218
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 57/186 (30%), Positives = 82/186 (44%), Gaps = 10/186 (5%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFE--NDIALLELETPIAYDSHIVPIC 166
V GEYD S +++ I N + VH +++ NDIAL++L +
Sbjct: 67 VLGEYDRSVLQGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLAN 126
Query: 167 MPKDDDDFTGRVAT-VSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN 225
+P D +SGWGRL GG +P LQE +PV++ C Q T+
Sbjct: 127 LPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQEALLPVVDYEHCS---QYDWWGITVKK 183
Query: 226 SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVS--HGIKCAAPYLPGVYMRTTY 283
+ +CAG R C+GDSGGPL DG W + G S C P V+ R +
Sbjct: 184 TMVCAG--GDTRSGCDGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSA 241
Query: 284 YKPWLQ 289
+ W+
Sbjct: 242 FIDWIN 247
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 59/173 (34%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + IC+P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 59/173 (34%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + IC+P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 58/189 (30%), Positives = 87/189 (46%), Gaps = 19/189 (10%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP 168
V G ++I E EA + ++ VH Y++ NDIA++ L P+ + I + +P
Sbjct: 52 VLGAHNIR-EDEATQ-VTIQSTDFTVHENYNSFVISNDIAVIRLPVPVTLTAAIATVGLP 109
Query: 169 KDDDDFTGRVATVSGWGRLKYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSF 227
D G V T +GWG G+ VL++V VP++ N C ++ I+S
Sbjct: 110 STDVG-VGTVVTPTGWGLPSDSALGISDVLRQVDVPIMSNADCDAVYGIVTDGNICIDS- 167
Query: 228 LCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIK--CAAPYLPGVYMRTTYYK 285
G + +C GDSGGPL + G S G C A Y P + R TY+
Sbjct: 168 ------TGGKGTCNGDSGGPLNYNG-----LTYGITSFGAAAGCEAGY-PDAFTRVTYFL 215
Query: 286 PWLQTITGV 294
W+QT TG+
Sbjct: 216 DWIQTQTGI 224
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 56/186 (30%), Positives = 83/186 (44%), Gaps = 15/186 (8%)
Query: 105 NLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVP 164
NL G++++ + +V R ++H YDAA+ + DI LL L P I P
Sbjct: 46 NLQVFLGKHNLG--QQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP 103
Query: 165 ICMPKDDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTII 224
+ + +D T + GWG+ G P +Q + ++ C+ + I
Sbjct: 104 LPLERDCSAQT-TSCHILGWGKTA-DGDFPDTIQCAYIHLVSREECEHAY-----PGQIT 156
Query: 225 NSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTY 283
+ LCAG +DSC+GDSGGPL+ L G VS G I C + PGVY
Sbjct: 157 QNMLCAGDEKYGKDSCQGDSGGPLVCGDH-----LRGLVSWGNIPCGSKEKPGVYTNVCR 211
Query: 284 YKPWLQ 289
Y W+Q
Sbjct: 212 YTNWIQ 217
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 59/173 (34%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + IC+P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 59/173 (34%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + IC+P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKEASTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/152 (34%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 144 ENDIALLELETP---IAYDSHIV-PICMPKDDDDF-TGRVATVSGWGRLKYG-GGVPSVL 197
++D+ L+ L+ A S V PIC+P+ F G ++GWG L G S L
Sbjct: 123 DHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSL 182
Query: 198 QEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHW 257
+E VP++ ++ C + I + LCAGY + + D+C+GDSGGPL E+ +G
Sbjct: 183 REALVPLVADHKCSS---PEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEK-NGVA 238
Query: 258 VLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
L G +S G C + PGVY R Y W+
Sbjct: 239 YLYGIISWGDGCGRLHKPGVYTRVANYVDWIN 270
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 59/173 (34%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + IC+P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKEASTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 52/152 (34%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 144 ENDIALLELETP---IAYDSHIV-PICMPKDDDDF-TGRVATVSGWGRLKYG-GGVPSVL 197
++D+ L+ L+ A S V PIC+P+ F G ++GWG L G S L
Sbjct: 88 DHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSL 147
Query: 198 QEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHW 257
+E VP++ ++ C + I + LCAGY + + D+C+GDSGGPL E+ +G
Sbjct: 148 REALVPLVADHKCSS---PEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEK-NGVA 203
Query: 258 VLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
L G +S G C + PGVY R Y W+
Sbjct: 204 YLYGIISWGDGCGRLHKPGVYTRVANYVDWIN 235
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 52/152 (34%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 144 ENDIALLELETP---IAYDSHIV-PICMPKDDDDF-TGRVATVSGWGRLKYG-GGVPSVL 197
++D+ L+ L+ A S V PIC+P+ F G ++GWG L G S L
Sbjct: 88 DHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSL 147
Query: 198 QEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHW 257
+E VP++ ++ C + I + LCAGY + + D+C+GDSGGPL E+ +G
Sbjct: 148 REALVPLVADHKCSS---PEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEK-NGVA 203
Query: 258 VLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
L G +S G C + PGVY R Y W+
Sbjct: 204 YLYGIISWGDGCGRLHKPGVYTRVANYVDWIN 235
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 58/173 (33%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + IC+P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + P L+ V +I + CQ Q + + LCA + D+
Sbjct: 137 ITGFGKEASTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDA 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 78.2 bits (191), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 26/168 (15%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLK 188
+R+ I +YD + ND+ LL L P + PI +P ++ G SGWG +
Sbjct: 82 MRKHIRFLEYD---YSNDLMLLRLSKPADITDTVKPITLPTEEPKL-GSTCLASGWGSI- 136
Query: 189 YGGGVPSVLQE------VQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEG 242
P+ Q V + ++ N C + H + + ++ LCAG +G +D+C+G
Sbjct: 137 ----TPTKFQFTDDLYCVNLKLLPNEDCAK-----AHIEKVTDAMLCAGEMDGGKDTCKG 187
Query: 243 DSGGPLMIEREDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTYYKPWLQ 289
DSGGPL+ DG VL G S G C P +PGVY + + W++
Sbjct: 188 DSGGPLIC---DG--VLQGITSWGHTPCGEPDMPGVYTKLNKFTSWIK 230
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 78.2 bits (191), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 9/167 (5%)
Query: 118 ELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGR 177
+L++ ++ +V+ + T+ D AL++L PI + + + FT
Sbjct: 61 DLQSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQPINQPTLKIATTTAYNQGTFT-- 118
Query: 178 VATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQR 237
V+GWG + GG L + VP + + C+ ++ + N +CAGY Q
Sbjct: 119 ---VAGWGANREGGSQQRYLLKANVPFVSDAACR----SSSSFILVANEMICAGYDTKQE 171
Query: 238 DSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
D+C+GDSGGP+ + WV G VS G CA GVY + +
Sbjct: 172 DTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTF 218
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 9/167 (5%)
Query: 118 ELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGR 177
+L++ ++ +V+ + T+ D AL++L PI + + + FT
Sbjct: 56 DLQSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQPINQPTLKIATTTAYNQGTFT-- 113
Query: 178 VATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQR 237
V+GWG + GG L + VP + + C+ ++ + N +CAGY Q
Sbjct: 114 ---VAGWGANREGGSQQRYLLKANVPFVSDAACR----SSSSFILVANEMICAGYDTKQE 166
Query: 238 DSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
D+C+GDSGGP+ + WV G VS G CA GVY + +
Sbjct: 167 DTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTF 213
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 12/168 (7%)
Query: 118 ELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGR 177
+L++ ++ +V+ Y+ D AL++L PI + + + FT
Sbjct: 56 DLQSSSAVKVRSTKVLQAPGYNGT--GKDWALIKLAQPINQPTLKIATTTAYNQGTFT-- 111
Query: 178 VATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYAN-GQ 236
V+GWG + GG L + VP + + C+ + + + N +CAGY + G
Sbjct: 112 ---VAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGN----ELVANEEICAGYPDTGG 164
Query: 237 RDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
D+C+GDSGGP+ + W+ G VS G CA P PGVY + +
Sbjct: 165 VDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTF 212
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 57/176 (32%), Positives = 85/176 (48%), Gaps = 21/176 (11%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLK 188
+ +VI H D +T DI L++L+ + + ++PIC+P D G V VSGWGR
Sbjct: 174 IEKVIFHP--DNSTV--DIGLIKLKQKVPVNERVMPICLPSKDYVNVGLVGYVSGWGR-N 228
Query: 189 YGGGVPSVLQEVQVPVIENNVCQEMFQ--TAGHAKT---------IINSF-LCAGYANGQ 236
L+ V +PV + C + ++ T KT I+N CAG + Q
Sbjct: 229 ANLNFTEHLKYVMLPVADQEKCVQYYEGSTVPEKKTPKSPVGVQPILNEHTFCAGLSKYQ 288
Query: 237 RDSCEGDSGGPLMI-EREDGHWVLAGTVSHGIKC-AAPYLPGVYMRTTYYKPWLQT 290
D+C GD+G + +++D W AG +S C A Y GVY+R T W+QT
Sbjct: 289 EDTCYGDAGSAFAVHDKDDDTWYAAGILSFDKSCRTAEY--GVYVRVTSILDWIQT 342
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 12/168 (7%)
Query: 118 ELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGR 177
+L++ ++ +V+ Y+ D AL++L PI + + + FT
Sbjct: 56 DLQSGAAVKVRSTKVLQAPGYNGT--GKDWALIKLAQPINQPTLKIATTTAYNQGTFT-- 111
Query: 178 VATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYAN-GQ 236
V+GWG + GG L + VP + + C+ + + + N +CAGY + G
Sbjct: 112 ---VAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGN----ELVANEEICAGYPDTGG 164
Query: 237 RDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
D+C+GDSGGP+ + W+ G VS G CA P PGVY + +
Sbjct: 165 VDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTF 212
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 12/162 (7%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVATVSGWGRL 187
V ++I H Y++ T NDI LL+L++ S + P+ +P+ + G V V+GWG+L
Sbjct: 72 VVKIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPLNLPRRNVKVKPGDVCYVAGWGKL 131
Query: 188 KYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGP 247
G LQEV++ V E+ C+ + I CAG +R S GDSGGP
Sbjct: 132 GPMGKYSDTLQEVELTVQEDQKCESYLKNYFDKANEI----CAGDPKIKRASFRGDSGGP 187
Query: 248 LMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
L+ ++ V AG VS+G + P + + + + W++
Sbjct: 188 LVCKK-----VAAGIVSYGQNDGS--TPRAFTKVSTFLSWIK 222
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 58/173 (33%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + I +P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKEQSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 12/168 (7%)
Query: 118 ELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGR 177
+L++ ++ +V+ Y+ D AL++L PI + + + FT
Sbjct: 56 DLQSSSAVKVRSTKVLQAPGYNGT--GKDWALIKLAQPINQPTLKIATTTAYNQGTFT-- 111
Query: 178 VATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYAN-GQ 236
V+GWG + GG L + VP + + C+ + + + N +CAGY + G
Sbjct: 112 ---VAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGN----ELVANEEICAGYPDTGG 164
Query: 237 RDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
D C+GDSGGP+ + W+ G VS G CA P PGVY + +
Sbjct: 165 VDPCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTF 212
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/173 (33%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + I +P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKEQSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/173 (33%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + I +P +D F G
Sbjct: 93 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQF-GTSCE 151
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 152 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 208
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 209 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 260
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/173 (33%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + I +P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/173 (33%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + I +P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 75.9 bits (185), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/173 (33%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + I +P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 75.9 bits (185), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 16/159 (10%)
Query: 139 DAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLKYGGG---VPS 195
D + +D+ LL L++P + + +P + + G SGWG ++ G P
Sbjct: 2 DGKDYSHDLMLLRLQSPAKITDAVKVLELPTQEPEL-GSTCEASGWGSIEPGPDDFEFPD 60
Query: 196 VLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDG 255
+Q VQ+ +++N C + H + S LCAGY G +D+C GDSGGPL+ +G
Sbjct: 61 EIQCVQLTLLQNTFCAD-----AHPDKVTESMLCAGYLPGGKDTCMGDSGGPLIC---NG 112
Query: 256 HWVLAGTVSHG-IKCAAPYLPGVYMRTTYYKPWL-QTIT 292
W G S G C + P +Y + +Y W+ TIT
Sbjct: 113 MW--QGITSWGHTPCGSANKPSIYTKLIFYLDWIDDTIT 149
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 75.9 bits (185), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/173 (33%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + I +P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GDSGGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 57/173 (32%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 129 VRRVIVHRQYDAATF--ENDIALLEL---ETPIAYDSHIV-PICMPK--DDDDFTGRVAT 180
V +I+H+ Y A T NDIALL++ E A S + I +P +D F G
Sbjct: 78 VENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQF-GTSCE 136
Query: 181 VSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDS 239
++G+G+ + + P L+ V +I + CQ Q + + LCA + DS
Sbjct: 137 ITGFGKEQSTDYLYPEQLKMTVVKLISHRECQ---QPHYYGSEVTTKMLCAADPQWKTDS 193
Query: 240 CEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTIT 292
C+GD+GGPL+ + G L G VS G CA PGVY R +++ PW+++ T
Sbjct: 194 CQGDAGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 55/185 (29%), Positives = 80/185 (43%), Gaps = 10/185 (5%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFE--NDIALLELETPIAYDSHIVPIC 166
V GEYD S +++ I N + VH +++ NDIAL++L +
Sbjct: 54 VLGEYDRSVLEGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLAN 113
Query: 167 MPKDDDDFTGRVAT-VSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN 225
+P D +SGWGRL GG +P LQ+ +P ++ C Q T+
Sbjct: 114 LPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQQALLPTVDYEHCS---QWDWWGITVKK 170
Query: 226 SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVS--HGIKCAAPYLPGVYMRTTY 283
+ +CAG R C GDSGGPL DG W + G S C P V+ R +
Sbjct: 171 TMVCAG--GDTRSGCNGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSA 228
Query: 284 YKPWL 288
+ W+
Sbjct: 229 FIDWI 233
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 12/150 (8%)
Query: 143 FENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQV 202
+ DI L+ L P+ Y +HI P+ +P R + GWG++ P V +
Sbjct: 85 LDKDIMLIRLRRPVTYSTHIAPVSLPSRSRGVGSR-CRIMGWGKISTTT-YPDVPHCTNI 142
Query: 203 PVIENNVCQEMF-QTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAG 261
++++ C+ ++ ++T LCAG G RD+C GDSGGPL+ E H ++AG
Sbjct: 143 FIVKHKWCEPLYPWVPADSRT-----LCAGILKGGRDTCHGDSGGPLICNGEM-HGIVAG 196
Query: 262 TVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
C P VY + Y W+Q+I
Sbjct: 197 GSE---PCGQHLKPAVYTKVFDYNNWIQSI 223
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 57/182 (31%), Positives = 82/182 (45%), Gaps = 15/182 (8%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
G Y +S E+ + + + V+ I H Y ND+ L++L I + PI +
Sbjct: 52 LGHYSLSPVYESGQQMFQGVKS-IPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPINVSS 110
Query: 170 DDDDFTGRVATVSGWGRLKYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFL 228
G VSGWG K P VLQ + + V+ C++ + + I ++
Sbjct: 111 HCPS-AGTKCLVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCEDAY-----PRQIDDTMF 164
Query: 229 CAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTYYKPW 287
CAG G RDSC+GDSGGP++ L G VS G CA P PGVY + W
Sbjct: 165 CAGDKAG-RDSCQGDSGGPVVCNGS-----LQGLVSWGDYPCARPNRPGVYTNLCKFTKW 218
Query: 288 LQ 289
+Q
Sbjct: 219 IQ 220
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 13/162 (8%)
Query: 130 RRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLKY 189
+ I + + + DI L++L+ PI+ HI P+ +P + G V + GWG +
Sbjct: 69 EKFICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPLSLPSNPPS-VGSVCRIMGWGSITI 127
Query: 190 GGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPL 248
P V + +++ VCQ + AKT LCAG G +D+C GDSGGPL
Sbjct: 128 PNETYPDVPYCANINLVDYEVCQGAYNGL-PAKTT----LCAGVLEGGKDTCVGDSGGPL 182
Query: 249 MIEREDGHWVLAGTVSHGI-KCAAPYLPGVYMRTTYYKPWLQ 289
+ + G VS+G C PG+Y Y W+Q
Sbjct: 183 ICNGQ-----FQGIVSYGAHSCGQGPKPGIYTNVFDYTDWIQ 219
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 11/167 (6%)
Query: 118 ELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGR 177
+L++ ++ +V+ Y+ D AL++L PI + + + FT
Sbjct: 56 DLQSSSAVKVRSTKVLQAPGYNGT--GKDWALIKLAQPINQPTLKIATTTAYNQGTFT-- 111
Query: 178 VATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQR 237
V+GWG + GG L + VP + + C+ + + + N +CAGY G
Sbjct: 112 ---VAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGN----ELVANEEICAGYDTGGV 164
Query: 238 DSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
D+C+GDSGGP+ + W+ G VS G CA GVY + +
Sbjct: 165 DTCQGDSGGPMFRKDNADEWIQVGIVSWGEGCARKGKYGVYTEVSTF 211
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 56/179 (31%), Positives = 82/179 (45%), Gaps = 18/179 (10%)
Query: 114 DISGELEAKR-SISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDD 172
D G+ A+R SK+ R H Y T ND+ L++L + S + + +P +
Sbjct: 54 DTLGDRRAQRIKASKSFR----HPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCE 109
Query: 173 DFTGRVATVSGWGRLKYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAG 231
G TVSGWG PS L V V +I C ++++ + NS LCAG
Sbjct: 110 P-PGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYK-----DLLENSMLCAG 163
Query: 232 YANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTYYKPWLQ 289
+ ++++C GDSGGPL+ L G VS G C P PGVY + + W+
Sbjct: 164 IPDSKKNACNGDSGGPLVCRG-----TLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWIN 217
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 55/165 (33%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 129 VRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVATVSGWGRL 187
VRR I H Y+ T NDI LL+L + PI +P+ + G + +V+GWGRL
Sbjct: 71 VRRPIPHPDYNDETLANDIMLLKLTRKADITDKVSPINLPRSLAEVKPGMMCSVAGWGRL 130
Query: 188 KYGGGVPSV--LQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSG 245
G +PS LQEV + V C F+ I + +CAG + +++S GDSG
Sbjct: 131 --GVNMPSTDKLQEVDLEVQSEEKCIARFKNY-----IPFTQICAGDPSKRKNSFSGDSG 183
Query: 246 GPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQT 290
GPL+ + V G VS+G P VY R + + W+ +
Sbjct: 184 GPLVC-----NGVAQGIVSYGRNDGT--TPDVYTRISSFLSWIHS 221
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 56/179 (31%), Positives = 82/179 (45%), Gaps = 18/179 (10%)
Query: 114 DISGELEAKR-SISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDD 172
D G+ A+R SK+ R H Y T ND+ L++L + S + + +P +
Sbjct: 54 DTLGDRRAQRIKASKSFR----HPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCE 109
Query: 173 DFTGRVATVSGWGRLKYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAG 231
G TVSGWG PS L V V +I C ++++ + NS LCAG
Sbjct: 110 P-PGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYK-----DLLENSMLCAG 163
Query: 232 YANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTYYKPWLQ 289
+ ++++C GDSGGPL+ L G VS G C P PGVY + + W+
Sbjct: 164 IPDSKKNACNGDSGGPLVCRG-----TLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWIN 217
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 13/156 (8%)
Query: 136 RQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLK-YGGGVP 194
RQ D + +D+ LL L P + V + ++ G SGWG ++ P
Sbjct: 87 RQADE-DYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFP 145
Query: 195 SVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIERED 254
LQ V + ++ N+ C++ H + + + LC G+ G +D+C GDSGGPLM D
Sbjct: 146 DDLQCVDLKILPNDECKK-----AHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMC---D 197
Query: 255 GHWVLAGTVSHG-IKCAAPYLPGVYMRTTYYKPWLQ 289
G VL G S G + C P P V +R Y W++
Sbjct: 198 G--VLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIE 231
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 14/186 (7%)
Query: 105 NLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVP 164
++ G ++I + E ++ I V + I H Y+ NDI LL+L + P
Sbjct: 50 SMTVTLGAHNIKAKEETQQIIP--VAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRP 107
Query: 165 ICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTI 223
+ +P+ + G V+GWG++ G P L EV++ V ++ VC+ FQ++ +
Sbjct: 108 LNLPRRNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNRANE 167
Query: 224 INSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTY 283
I C G + + S GDSGGPL+ +R AG VS+G + P V+ R
Sbjct: 168 I----CVGDSKIKGASFRGDSGGPLVCKR-----AAAGIVSYGQTDGS--APQVFTRVLS 216
Query: 284 YKPWLQ 289
+ W++
Sbjct: 217 FVSWIK 222
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 16/188 (8%)
Query: 105 NLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVP 164
++ G ++I+ E + + + V + H +Y+ +T +DI LL+L+ + +
Sbjct: 50 SITVTLGAHNITEEEDTWQKL--EVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGT 107
Query: 165 ICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTI 223
+ P + GR+ V+GWGR LQEV++ +++ C F+ H
Sbjct: 108 LPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSH-FRDFDH---- 162
Query: 224 INSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTY 283
N LC G + + +GDSGGPL+ V G VS+G A P P V+ R ++
Sbjct: 163 -NLQLCVGNPRKTKSAFKGDSGGPLLCAG-----VAQGIVSYGRSDAKP--PAVFTRISH 214
Query: 284 YKPWLQTI 291
Y+PW+ I
Sbjct: 215 YRPWINQI 222
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 16/188 (8%)
Query: 105 NLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVP 164
++ G ++I+ E + + + V + H +Y+ +T +DI LL+L+ + +
Sbjct: 50 SITVTLGAHNITEEEDTWQKL--EVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGT 107
Query: 165 ICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTI 223
+ P + GR+ V+GWGR LQEV++ +++ C F+ H
Sbjct: 108 LPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSH-FRDFDH---- 162
Query: 224 INSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTY 283
N LC G + + +GDSGGPL+ V G VS+G A P P V+ R ++
Sbjct: 163 -NLQLCVGNPRKTKSAFKGDSGGPLLCAG-----VAQGIVSYGRSDAKP--PAVFTRISH 214
Query: 284 YKPWLQTI 291
Y+PW+ I
Sbjct: 215 YRPWINQI 222
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 16/188 (8%)
Query: 105 NLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVP 164
++ G ++I+ E + + + V + H +Y+ +T +DI LL+L+ + +
Sbjct: 52 SITVTLGAHNITEEEDTWQKLE--VIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGT 109
Query: 165 ICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTI 223
+ P + GR+ V+GWGR LQEV++ +++ C F+ H
Sbjct: 110 LPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSH-FRDFDH---- 164
Query: 224 INSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTY 283
N LC G + + +GDSGGPL+ V G VS+G A P P V+ R ++
Sbjct: 165 -NLQLCVGNPRKTKSAFKGDSGGPLLCAG-----VAQGIVSYGRSDAKP--PAVFTRISH 216
Query: 284 YKPWLQTI 291
Y+PW+ I
Sbjct: 217 YRPWINQI 224
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 71.6 bits (174), Expect = 5e-13, Method: Composition-based stats.
Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 190 GGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLM 249
G PS+LQ ++ PV+ N+ C+ + + I + +C G+ G +DSC+GDSGGP++
Sbjct: 3 GSSYPSLLQCLKAPVLSNSSCK-----SSYPGQITGNMICVGFLQGGKDSCQGDSGGPVV 57
Query: 250 IEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
+ L G VS G CA PGVY + Y W+Q
Sbjct: 58 CNGQ-----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 92
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
N+ +++ A F +D+ LL L P + PI +P + G SGWG +
Sbjct: 78 NMSLLMLQTIPPGADFSDDLMLLRLSKPADITDVVKPIALPTKEPK-PGSKCLASGWGSI 136
Query: 188 K-YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGG 246
P LQ V + ++ N C +++ + + + LCAG G +D+C DSGG
Sbjct: 137 TPTRWQKPDDLQCVFITLLPNENCAKVY-----LQKVTDVMLCAGEMGGGKDTCRDDSGG 191
Query: 247 PLMIEREDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTYYKPWLQ 289
PL+ DG +L GT S+G + C P +P +Y + W++
Sbjct: 192 PLIC---DG--ILQGTTSYGPVPCGKPGVPAIYTNLIKFNSWIK 230
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 51/175 (29%), Positives = 77/175 (44%), Gaps = 24/175 (13%)
Query: 128 NVRRVIVHRQYDAATFEN-----------DIALLELETPIAYDSHIVPICMPKDDDDFTG 176
V H YD + +N D+ LL L P + + +P + G
Sbjct: 67 QVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAVKVMDLPTQEPAL-G 125
Query: 177 RVATVSGWGRLKYGGGV-PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANG 235
SGWG ++ + P LQ V + VI N+VC ++ H + + LCAG G
Sbjct: 126 TTCYASGWGSIEPEEFLTPKKLQCVDLHVISNDVCAQV-----HPQKVTKFMLCAGRWTG 180
Query: 236 QRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYMRTTYYKPWLQ 289
+ +C GDSGGPL+ VL G S G + CA P P +Y + +Y+ W++
Sbjct: 181 GKSTCSGDSGGPLVCNG-----VLQGITSWGSEPCALPERPSLYTKVVHYRKWIK 230
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 71.2 bits (173), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 14/186 (7%)
Query: 105 NLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVP 164
++ G ++I + E ++ I V + I H Y+ NDI LL+L + P
Sbjct: 50 SMTVTLGAHNIKAKEETQQIIP--VAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRP 107
Query: 165 ICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTI 223
+ +P+ + G V+GWG++ G P L EV++ V ++ VC+ FQ++ +
Sbjct: 108 LNLPRRNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNRANE 167
Query: 224 INSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTY 283
I C G + + S E DSGGPL+ +R AG VS+G + P V+ R
Sbjct: 168 I----CVGDSKIKGASFEEDSGGPLVCKR-----AAAGIVSYGQTDGS--APQVFTRVLS 216
Query: 284 YKPWLQ 289
+ W++
Sbjct: 217 FVSWIK 222
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 71.2 bits (173), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 16/188 (8%)
Query: 105 NLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVP 164
++ G ++I+ E + + + V + H +Y+ +T +DI LL+L+ + +
Sbjct: 50 SITVTLGAHNITEEEDTWQKL--EVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGT 107
Query: 165 ICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTI 223
+ P + GR+ V+GWGR LQEV++ +++ C F+ H
Sbjct: 108 LPFPSQKNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSH-FRDFDH---- 162
Query: 224 INSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTY 283
N LC G + + +GDSGGPL+ G VS+G A P P V+ R ++
Sbjct: 163 -NLQLCVGNPRKTKSAFKGDSGGPLLCAG-----AAQGIVSYGRSDAKP--PAVFTRISH 214
Query: 284 YKPWLQTI 291
Y+PW+ I
Sbjct: 215 YQPWINQI 222
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 71.2 bits (173), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 103 LANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAA-TFENDIALLELETPIAYDSH 161
+A L V G + + ++ +++ I H +Y END+ALL+L+ +
Sbjct: 47 MAQLRLVLGLHTLDSP-----GLTFHIKAAIQHPRYKPVPALENDLALLQLDGKVKPSRT 101
Query: 162 IVPICMP-KDDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHA 220
I P+ +P K G +++GWG GG + VL+E+ + V++ +C G
Sbjct: 102 IRPLALPSKRQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNG-- 159
Query: 221 KTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYM 279
++ S +C + + C+GDSGGPL+ + VLAG +S + C + P V
Sbjct: 160 -SLSPSMVCLAADSKDQAPCKGDSGGPLVCGKGR---VLAGVLSFSSRVCTDIFKPPVAT 215
Query: 280 RTTYYKPWLQTITG 293
Y W++ +TG
Sbjct: 216 AVAPYVSWIRKVTG 229
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 48/188 (25%), Positives = 89/188 (47%), Gaps = 12/188 (6%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQY--DAATFENDIALLELETPIAYDSHIVPIC 166
V GE++++ ++ + V++++VH + D DIALL L + +S++
Sbjct: 56 VVGEHNLNQNNGTEQYVG--VQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGV 113
Query: 167 MPKDDDDFTGRV-ATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN 225
+P+ ++GWG + G + LQ+ +P ++ +C ++ T+ N
Sbjct: 114 LPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSS---SSYWGSTVKN 170
Query: 226 SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVS--HGIKCAAPYLPGVYMRTTY 283
S +CAG +G R C+GDSGGPL +G + + G S + C P V+ R +
Sbjct: 171 SMVCAG-GDGVRSGCQGDSGGPLHC-LVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSA 228
Query: 284 YKPWLQTI 291
Y W+ +
Sbjct: 229 YISWINNV 236
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 48/188 (25%), Positives = 89/188 (47%), Gaps = 12/188 (6%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQY--DAATFENDIALLELETPIAYDSHIVPIC 166
V GE++++ ++ + V++++VH + D DIALL L + +S++
Sbjct: 56 VVGEHNLNQNDGTEQYVG--VQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGV 113
Query: 167 MPKDDDDFTGRV-ATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN 225
+P+ ++GWG + G + LQ+ +P ++ +C ++ T+ N
Sbjct: 114 LPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSS---SSYWGSTVKN 170
Query: 226 SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVS--HGIKCAAPYLPGVYMRTTY 283
S +CAG +G R C+GDSGGPL +G + + G S + C P V+ R +
Sbjct: 171 SMVCAG-GDGVRSGCQGDSGGPLHC-LVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSA 228
Query: 284 YKPWLQTI 291
Y W+ +
Sbjct: 229 YISWINNV 236
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 142 TFENDIALLELETPIAYDSHIVPICMPKDDDDFT---GRVATVSGWGRLKYGGGVPSVLQ 198
F+NDIAL+ L+ P+ + PIC+P D+ G + +SGWGR + L+
Sbjct: 170 NFDNDIALVRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLISGWGRTEKRDRA-VRLK 228
Query: 199 EVQVPVIENNVCQEMF----QTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIE--R 252
++PV C+E+ A + +CAG G DSC+GDSGG ++
Sbjct: 229 AARLPVAPLRKCKEVKVEKPTADAEAYVFTPNMICAGGEKGM-DSCKGDSGGAFAVQDPN 287
Query: 253 EDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWL 288
+ + AG VS G +C G+Y R Y W+
Sbjct: 288 DKTKFYAAGLVSWGPQCGT---YGLYTRVKNYVDWI 320
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 18/173 (10%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKD---DDDFTGRVATVSGW 184
N R+I H ++ T+ ND+AL+++ + Y +I PI +P ++ F ATVSGW
Sbjct: 70 NSERIISHSMFNPDTYLNDVALIKIPH-VEYTDNIQPIRLPSGEELNNKFENIWATVSGW 128
Query: 185 GRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDS 244
G+ +LQ VI+N+ C + + I+ S +C ++G + C GDS
Sbjct: 129 GQSNTD---TVILQYTYNLVIDNDRCAQEYPPG----IIVESTICGDTSDG-KSPCFGDS 180
Query: 245 GGPLMIEREDGHWVLAGTVS--HGIKCAAPYLPGVYMRTTYYKPWLQTITGVQ 295
GGP ++ ++ +L G VS G C + P + R T Y W+Q TG++
Sbjct: 181 GGPFVLSDKN---LLIGVVSFVSGAGCESGK-PVGFSRVTSYMDWIQQNTGIK 229
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 48/188 (25%), Positives = 89/188 (47%), Gaps = 12/188 (6%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQY--DAATFENDIALLELETPIAYDSHIVPIC 166
V GE++++ ++ + V++++VH + D DIALL L + +S++
Sbjct: 56 VVGEHNLNQNNGTEQYVG--VQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGV 113
Query: 167 MPKDDDDFTGRV-ATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN 225
+P+ ++GWG + G + LQ+ +P ++ +C ++ T+ N
Sbjct: 114 LPRAGTILRNNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSS---SSYWGSTVKN 170
Query: 226 SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVS--HGIKCAAPYLPGVYMRTTY 283
S +CAG +G R C+GDSGGPL +G + + G S + C P V+ R +
Sbjct: 171 SMVCAG-GDGVRSGCQGDSGGPLHC-LVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSA 228
Query: 284 YKPWLQTI 291
Y W+ +
Sbjct: 229 YISWINNV 236
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 21/168 (12%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWG-- 185
N+ + H + ND+ LL L P + PI +P ++ G SGWG
Sbjct: 81 NMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPITLPTEEPKL-GSTCLASGWGST 139
Query: 186 ---RLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEG 242
+ KY P LQ V + ++ N C + H + ++ LCAG +G +CE
Sbjct: 140 TPIKFKY----PDDLQCVNLKLLPNEDCDK-----AHEMKVTDAMLCAGEMDGGSYTCEH 190
Query: 243 DSGGPLMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYMRTTYYKPWLQ 289
DSGGPL+ DG +L G S G + C P P VY + + W++
Sbjct: 191 DSGGPLIC---DG--ILQGITSWGPEPCGEPTEPSVYTKLIKFSSWIR 233
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 16/188 (8%)
Query: 105 NLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVP 164
++ G ++I+ E + + + V + H +Y+ +T +DI LL+L+ + +
Sbjct: 50 SITVTLGAHNITEEEDTWQKL--EVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGT 107
Query: 165 ICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTI 223
+ P + GR+ V+GWGR LQEV++ +++ C F+ H
Sbjct: 108 LPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSH-FRDFDH---- 162
Query: 224 INSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTY 283
N LC G + + +GDSGGPL+ G VS+G A P P V+ R ++
Sbjct: 163 -NLQLCVGNPRKTKSAFKGDSGGPLLCAG-----AAQGIVSYGRSDAKP--PAVFTRISH 214
Query: 284 YKPWLQTI 291
Y+PW+ I
Sbjct: 215 YQPWINQI 222
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 70.1 bits (170), Expect = 2e-12, Method: Composition-based stats.
Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 190 GGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLM 249
G PS+LQ ++ PV+ ++ C+ + + I + +C G+ G +DSC+GDSGGP++
Sbjct: 3 GSSYPSLLQCLKAPVLSDSSCK-----SSYPGQITGNMICVGFLEGGKDSCQGDSGGPVV 57
Query: 250 IEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
+ L G VS G CA PGVY + Y W+Q
Sbjct: 58 CNGQ-----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 92
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 38/98 (38%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 194 PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIERE 253
P LQ+ +P++ C++ + I + CAG + DSC GDSGGPL+ ++
Sbjct: 6 PEKLQQAALPIVSEADCKKSW-----GSKITDVMTCAGASG--VDSCMGDSGGPLVCQK- 57
Query: 254 DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
DG W LAG VS G + PGVY R T PW+Q I
Sbjct: 58 DGVWTLAGIVSWGSGVCSTSTPGVYSRVTALMPWVQQI 95
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 103 LANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAA-TFENDIALLELETPIAYDSH 161
+A L V G + + ++ +++ I H +Y EN++ALL+L+ +
Sbjct: 47 MAQLRLVLGLHTLDSP-----GLTFHIKAAIQHPRYKPVPALENNLALLQLDGKVKPSRT 101
Query: 162 IVPICMP-KDDDDFTGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHA 220
I P+ +P K G +++GWG GG + VL+E+ + V++ +C G
Sbjct: 102 IRPLALPSKRQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNG-- 159
Query: 221 KTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYM 279
++ S +C + + C+GDSGGPL+ + VLAG +S + C + P V
Sbjct: 160 -SLSPSMVCLAADSKDQAPCKGDSGGPLVCGKGR---VLAGVLSFSSRVCTDIFKPPVAT 215
Query: 280 RTTYYKPWLQTITG 293
Y W++ +TG
Sbjct: 216 AVAPYVSWIRKVTG 229
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 23/193 (11%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFEN--DIALLELETPIAYDSHIVPIC 166
V GE++++ E K I V V +H +++ DIALL L T + +S +
Sbjct: 56 VLGEHNLNTN-EGKEQI-MTVNSVFIHSGWNSDDVAGGYDIALLRLNTQASLNSAVQLAA 113
Query: 167 MPKDDDDF-TGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN 225
+P + ++GWG+ GG + L++ +P +++ C + T+
Sbjct: 114 LPPSNQILPNNNPCYITGWGKTSTGGPLSDSLKQAWLPSVDHATCSS---SGWWGSTVKT 170
Query: 226 SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIK-------CAAPYLPGVY 278
+ +CAG G C GDSGGPL + ++V HG+ C A P V+
Sbjct: 171 TMVCAG--GGANSGCNGDSGGPLNCQVNGSYYV------HGVTSFVSSSGCNASKKPTVF 222
Query: 279 MRTTYYKPWLQTI 291
R + Y W+ I
Sbjct: 223 TRVSAYISWMNGI 235
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/158 (33%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 133 IVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLKYGGG 192
+ H +Y+ ND+ L++L+ ++ I I + G VSGWG L G
Sbjct: 73 VRHPEYNRPLLANDLMLIKLDESVSESDTIRSISIASQCPT-AGNSCLVSGWGLLA-NGR 130
Query: 193 VPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIER 252
+P+VLQ V V V+ VC +++ H S CAG Q+DSC GDSGGPL+
Sbjct: 131 MPTVLQCVNVSVVSEEVCSKLYDPLYHP-----SMFCAGGGQDQKDSCNGDSGGPLIC-- 183
Query: 253 EDGHWVLAGTVSHG-IKCAAPYLPGVYMRTTYYKPWLQ 289
+G+ L G VS G C +PGVY + W++
Sbjct: 184 -NGY--LQGLVSFGKAPCGQVGVPGVYTNLCKFTEWIE 218
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 48/149 (32%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 145 NDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLKYGGGVPS-VLQEVQVP 203
ND+ LL L P + I +P + G SGWG V S LQ V +
Sbjct: 93 NDLMLLHLSEPADITGGVKVIDLPTKEPKV-GSTCLASGWGSTNPSEMVVSHDLQCVNIH 151
Query: 204 VIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTV 263
++ N C E ++ + + LCAG G +D+C GDSGGPL+ DG VL G
Sbjct: 152 LLSNEKCIETYK-----DNVTDVMLCAGEMEGGKDTCAGDSGGPLIC---DG--VLQGIT 201
Query: 264 SHG-IKCAAPYLPGVYMRTTYYKPWLQTI 291
S G CA P P +Y + + W++ +
Sbjct: 202 SGGATPCAKPKTPAIYAKLIKFTSWIKKV 230
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 14/187 (7%)
Query: 104 ANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIV 163
+++ G ++I + ++ I V+R I H Y+ F NDI LL+LE +
Sbjct: 48 SSINVTLGAHNIKEQEPTQQFIP--VKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQ 105
Query: 164 PICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKT 222
P+ +P + G+ +V+GWG+ G LQEV++ V E+ C+ + + T
Sbjct: 106 PLRLPSNKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHY-YDST 164
Query: 223 IINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTT 282
I LC G ++ S +GDSGGPL+ + V G VS+G P P + +
Sbjct: 165 I---ELCVGDPEIKKTSFKGDSGGPLVCNK-----VAQGIVSYGRNNGMP--PRACTKVS 214
Query: 283 YYKPWLQ 289
+ W++
Sbjct: 215 SFVHWIK 221
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 14/187 (7%)
Query: 104 ANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIV 163
+++ G ++I + ++ I V+R I H Y+ F NDI LL+LE +
Sbjct: 48 SSINVTLGAHNIKEQEPTQQFIP--VKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQ 105
Query: 164 PICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKT 222
P+ +P + G+ +V+GWG+ G LQEV++ V E+ C+ + + T
Sbjct: 106 PLRLPSNKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHY-YDST 164
Query: 223 IINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTT 282
I LC G ++ S +GDSGGPL+ + V G VS+G P P + +
Sbjct: 165 I---ELCVGDPEIKKTSFKGDSGGPLVCNK-----VAQGIVSYGRNNGMP--PRACTKVS 214
Query: 283 YYKPWLQ 289
+ W++
Sbjct: 215 SFVHWIK 221
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 67.4 bits (163), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 194 PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIERE 253
P LQ+ +P++ C++ + I + CAG + DSC GDSGGPL+ ++
Sbjct: 6 PEKLQQAALPIVSEADCKKSW-----GSKITDVMTCAGASG--VDSCMGDSGGPLVCQK- 57
Query: 254 DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
DG W LAG VS G + P VY R T PW+Q I
Sbjct: 58 DGVWTLAGIVSWGSGVCSTSTPAVYSRVTALMPWVQQI 95
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 46/154 (29%), Positives = 72/154 (46%), Gaps = 16/154 (10%)
Query: 143 FENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLK-YGGGVPSVLQEVQ 201
++ DI L+ L++P+ HI P G V + GWGR+ G P V V
Sbjct: 85 WDKDIMLIRLDSPVKNSKHIAPF-SLPSSPPSVGSVCRIMGWGRISPTEGTYPDVPHCVN 143
Query: 202 VPVIENNVCQE---MFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWV 258
+ ++E +C+ F+ ++T LCAG G +D+C+GDSGGPL+ +
Sbjct: 144 INLLEYEMCRAPYPEFELPATSRT-----LCAGILEGGKDTCKGDSGGPLICNGQ----- 193
Query: 259 LAGTVSHGIK-CAAPYLPGVYMRTTYYKPWLQTI 291
G S G CA P+ P Y + + W++ I
Sbjct: 194 FQGIASWGDDPCAQPHKPAAYTKVFDHLDWIENI 227
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 20/194 (10%)
Query: 103 LANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHI 162
L + A G +D+ G + K NV +++ + +D+ L++L P D +
Sbjct: 47 LKDYEAWLGIHDVHGRGDEKCKQVLNVSQLVYGPE------GSDLVLMKLARPAVLDDFV 100
Query: 163 VPICMPKDDDDFTGRVA-TVSGWGR---LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAG 218
I +P + + +V GWG + Y G +L+ + ++ N C + +
Sbjct: 101 STIDLPNYGSTIPEKTSCSVYGWGYTGLINYDG----LLRVAHLYIMGNEKCSQHHR--- 153
Query: 219 HAKTIIN-SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGV 277
K +N S +CAG CEGD GGPL+ E+ VL G + G CA P PG+
Sbjct: 154 -GKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVL-GVIVPGRGCAIPNRPGI 211
Query: 278 YMRTTYYKPWLQTI 291
++R YY W+ I
Sbjct: 212 FVRVAYYAKWIHKI 225
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 20/194 (10%)
Query: 103 LANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHI 162
L + A G +D+ G + K NV +++ + +D+ L++L P D +
Sbjct: 47 LKDYEAWLGIHDVHGRGDEKCKQVLNVSQLVYGPE------GSDLVLMKLARPAVLDDFV 100
Query: 163 VPICMPKDDDDFTGRVA-TVSGWGR---LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAG 218
I +P + + +V GWG + Y G +L+ + ++ N C + +
Sbjct: 101 STIDLPNYGSTIPEKTSCSVYGWGYTGLINYDG----LLRVAHLYIMGNEKCSQHHR--- 153
Query: 219 HAKTIIN-SFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGV 277
K +N S +CAG CEGD GGPL+ E+ VL G + G CA P PG+
Sbjct: 154 -GKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVL-GVIVPGRGCAIPNRPGI 211
Query: 278 YMRTTYYKPWLQTI 291
++R YY W+ I
Sbjct: 212 FVRVAYYAKWIHKI 225
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 12/150 (8%)
Query: 144 ENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLKYGGGV-PSVLQEVQV 202
+ DI L++L++ ++ HI P+ G V + GWG+ + P V +
Sbjct: 84 DKDIMLIKLDSSVSNSEHIAPL-SLPSSPPSVGSVCRIMGWGKTIPTKEIYPDVPHCANI 142
Query: 203 PVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGT 262
++++ VC+ TA + + N+ LCAG G RD+C DSGGPL+ + G
Sbjct: 143 NILDHAVCR----TAYSWRQVANTTLCAGILQGGRDTCHFDSGGPLICNG-----IFQGI 193
Query: 263 VSHGIK-CAAPYLPGVYMRTTYYKPWLQTI 291
VS G C P PGVY + Y W+++I
Sbjct: 194 VSWGGHPCGQPGEPGVYTKVFDYLDWIKSI 223
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 48/174 (27%), Positives = 74/174 (42%), Gaps = 34/174 (19%)
Query: 129 VRRVIVHRQYDAATFENDIALLELE-----------TPIAYDSHIVPICMPKDDDDFTGR 177
V + H +YD NDI LL+L+ PI+ S+ +P GR
Sbjct: 72 VEKQFPHPKYDDRLVLNDIMLLKLKEKANLTLGVGTLPISAKSNSIP----------PGR 121
Query: 178 VATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQR 237
V GWGR LQEV++ +++ C+ + LC G R
Sbjct: 122 VCRAVGWGRTNVNEPPSDTLQEVKMRILDPQACKHFEDFHQEPQ------LCVGNPKKIR 175
Query: 238 DSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+ +GDSGGPL+ + G S+ ++ A P P V+ R ++Y+PW+ I
Sbjct: 176 NVYKGDSGGPLLCA-----GIAQGIASYVLRNAKP--PSVFTRISHYRPWINKI 222
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 65.1 bits (157), Expect = 4e-11, Method: Composition-based stats.
Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 8/96 (8%)
Query: 194 PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIERE 253
P LQ+ +P++ N C++ + T I ++ +CAG A+G SC GDSGGPL+ ++
Sbjct: 4 PDRLQQASLPLLSNTNCKKYWGT-----KIKDAMICAG-ASGV-SSCMGDSGGPLVCKK- 55
Query: 254 DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
+G W L G VS G + PGVY R T W+Q
Sbjct: 56 NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ 91
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 65.1 bits (157), Expect = 4e-11, Method: Composition-based stats.
Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 8/96 (8%)
Query: 194 PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIERE 253
P LQ+ +P++ N C++ + T I ++ +CAG A+G SC GDSGGPL+ ++
Sbjct: 3 PDRLQQASLPLLSNTNCKKYWGT-----KIKDAMICAG-ASGV-SSCMGDSGGPLVCKK- 54
Query: 254 DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQ 289
+G W L G VS G + PGVY R T W+Q
Sbjct: 55 NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ 90
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 27/189 (14%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFEN---DIALLELETPIAYDSHIVPIC 166
G++ + + ++ I V + I H Y+ + E+ DI L+ L+ + P+
Sbjct: 51 LGDHSLQSRDQPEQEI--QVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQ 108
Query: 167 M----PKDDDDFTGRVATVSGWGRLKYGG-GVPSVLQEVQVPVIENNVCQEMFQTAGHAK 221
+ PK G+ +SGWG + P+ L +V + N C+ +
Sbjct: 109 LANLCPK-----VGQKCIISGWGTVTSPQENFPNTLNCAEVKIYSQNKCERAY-----PG 158
Query: 222 TIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYMR 280
I +CAG +NG D+C+GDSGGPL+ DG +L G S G C P PGVY +
Sbjct: 159 KITEGMVCAGSSNG-ADTCQGDSGGPLVC---DG--MLQGITSWGSDPCGKPEKPGVYTK 212
Query: 281 TTYYKPWLQ 289
Y W++
Sbjct: 213 ICRYTTWIK 221
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 63.9 bits (154), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 130 RRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWG---- 185
+ I + + + DI L++L++ ++ HIVP+ G V + GWG
Sbjct: 70 EKFICPNKKNDEVLDKDIMLIKLDSRVSNSEHIVPL-SLPSSPPSVGSVCHIMGWGSITP 128
Query: 186 -RLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN-SFLCAGYANGQRDSCEGD 243
++ Y P V + ++++ VCQ AG+ + + LCAG G +D+C GD
Sbjct: 129 IKVTY----PDVPYCAYINLLDDAVCQ-----AGYPELLTEYRTLCAGILEGGKDTCGGD 179
Query: 244 SGGPLMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYMRTTYYKPWLQTI 291
SGGPL+ + G VS G C PGVY + Y W+Q+I
Sbjct: 180 SGGPLICNGQ-----FQGIVSFGAHPCGQGLKPGVYTKVFDYNHWIQSI 223
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 14/163 (8%)
Query: 130 RRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLK- 188
+ I + + + DI L++L+ PI+ HI P+ G V + GWG +
Sbjct: 70 EKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPL-SLPSSPPSVGSVCRIMGWGSITP 128
Query: 189 YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN-SFLCAGYANGQRDSCEGDSGGP 247
P V + ++++ VCQ AG+ + + LCAG G +D+C GDSGGP
Sbjct: 129 VKETFPDVPYCANINLLDHAVCQ-----AGYPELLAEYRTLCAGIVQGGKDTCGGDSGGP 183
Query: 248 LMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYMRTTYYKPWLQ 289
L+ + G VS+G C PG+Y Y W+Q
Sbjct: 184 LICNGQ-----FQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQ 221
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 14/163 (8%)
Query: 130 RRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLK- 188
+ I + + + DI L++L+ PI+ HI P+ G V + GWG +
Sbjct: 70 EKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPL-SLPSSPPSVGSVCRIMGWGSITP 128
Query: 189 YGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIIN-SFLCAGYANGQRDSCEGDSGGP 247
P V + ++++ VCQ AG+ + + LCAG G +D+C GDSGGP
Sbjct: 129 VKETFPDVPYCANINLLDHAVCQ-----AGYPELLAEYRTLCAGIVQGGKDTCGGDSGGP 183
Query: 248 LMIEREDGHWVLAGTVSHGIK-CAAPYLPGVYMRTTYYKPWLQ 289
L+ + G VS+G C PG+Y Y W+Q
Sbjct: 184 LICNGQ-----FQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQ 221
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 9/104 (8%)
Query: 192 GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--NGQR-DSCEGDSGGPL 248
G PSVLQ V +P++E VC++ + I ++ CAGY G+R D+CEGDSGGP
Sbjct: 1 GQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKPDEGKRGDACEGDSGGPF 55
Query: 249 MIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+++ + W G VS G C G Y K W+Q +
Sbjct: 56 VMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 99
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 9/104 (8%)
Query: 192 GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYA--NGQR-DSCEGDSGGPL 248
G PSVLQ V +P++E VC++ + I ++ CAGY G+R D+CEGDSGGP
Sbjct: 1 GQPSVLQVVNLPIVERPVCKDSTRI-----RITDNMFCAGYKPDEGKRGDACEGDSGGPF 55
Query: 249 MIERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+++ + W G VS G C G Y K W+Q +
Sbjct: 56 VMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 99
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 47/193 (24%), Positives = 82/193 (42%), Gaps = 28/193 (14%)
Query: 106 LVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPI 165
+ + G +D+ ++ I V + I+H Y++ +DI LL+LE + + +
Sbjct: 51 ITVILGAHDVRKRESTQQKI--KVEKQIIHESYNSVPNLHDIMLLKLEKKVELTPAVNVV 108
Query: 166 CMPKDDDDF-TGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEM------FQTAG 218
+P D G + +GWG+ L+EV++ +++ C + FQ
Sbjct: 109 PLPSPSDFIHPGAMCWAAGWGKTGVRDPTSYTLREVELRIMDEKACVDYRYYEYKFQ--- 165
Query: 219 HAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVY 278
+C G R + GDSGGPL+ V G VS+G A P P ++
Sbjct: 166 ---------VCVGSPTTLRAAFMGDSGGPLLCAG-----VAHGIVSYGHPDAKP--PAIF 209
Query: 279 MRTTYYKPWLQTI 291
R + Y PW+ +
Sbjct: 210 TRVSTYVPWINAV 222
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 37/102 (36%), Positives = 51/102 (50%), Gaps = 9/102 (8%)
Query: 194 PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQR---DSCEGDSGGPLMI 250
PSVLQ V +P++E VC+ A I ++ CAGY G+ D+CEGDSGGP ++
Sbjct: 7 PSVLQVVNLPLVERPVCK-----ASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVM 61
Query: 251 ERE-DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
+ + W G VS G C G Y K W+Q +
Sbjct: 62 KSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKV 103
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 3/98 (3%)
Query: 93 FTINLSKIGFLANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLEL 152
+ + + G + V V GE+D + E + + + +V + +++ T NDI LL+L
Sbjct: 33 WVVTAAHCGVKTSDVVVAGEFDQGSDEENIQVL--KIAQVFKNPKFNMFTVRNDITLLKL 90
Query: 153 ETPIAYDSHIVPICMPKDDDDF-TGRVATVSGWGRLKY 189
TP + + +C+P DDDF G V +GWG+ KY
Sbjct: 91 ATPAQFSETVSAVCLPNVDDDFPPGTVCATTGWGKTKY 128
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 41/148 (27%), Positives = 63/148 (42%), Gaps = 8/148 (5%)
Query: 145 NDIALLELETPIAYDSHIVPICMPKDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVP 203
+ + LL+LE + + + IC+P + G ++GWG K G G +VL +
Sbjct: 84 SQLVLLKLERSVTLNQRVALICLPPEWYVVPPGTKCEIAGWGETK-GTGNDTVLNVALLN 142
Query: 204 VIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTV 263
VI N C H + S +C +CEGD GGPL + WVL G +
Sbjct: 143 VISNQECN-----IKHRGRVRESEMCTEGLLAPVGACEGDYGGPLACFTHNS-WVLEGII 196
Query: 264 SHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
CA P V+ R + + W+ +
Sbjct: 197 IPNRVCARSRWPAVFTRVSVFVDWIHKV 224
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 48/98 (48%), Gaps = 3/98 (3%)
Query: 93 FTINLSKIGFLANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLEL 152
+ + + G + V V GE+D E + + + +V + +Y++ T NDI LL+L
Sbjct: 36 WVVTAAHCGVTTSDVVVAGEFDQGSSSEKIQKL--KIAKVFKNSKYNSLTINNDITLLKL 93
Query: 153 ETPIAYDSHIVPICMPKDDDDF-TGRVATVSGWGRLKY 189
T ++ + +C+P DDF G +GWG +Y
Sbjct: 94 STAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRY 131
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 3/98 (3%)
Query: 93 FTINLSKIGFLANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLEL 152
+ + + G + V V GE+D + E + + + +V + +++ T NDI LL+L
Sbjct: 36 WVVTAAHCGVKTSDVVVAGEFDQGSDEENIQVL--KIAQVFKNPKFNMFTVRNDITLLKL 93
Query: 153 ETPIAYDSHIVPICMPKDDDDF-TGRVATVSGWGRLKY 189
TP + + + +P DDDF G V +GWG+ KY
Sbjct: 94 ATPAQFSETVSAVSLPNVDDDFPPGTVCATTGWGKTKY 131
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 24/184 (13%)
Query: 109 VFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMP 168
V G +++ + ++ S V +V ++ YDA NDI L++L +P + + + +P
Sbjct: 57 VLGAHNVRTQEPTQQHFS--VAQVFLN-NYDAENKLNDILLIQLSSPANLSASVATVQLP 113
Query: 169 KDDDDFT-GRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSF 227
+ D G GWGR+ VLQE+ V V+ F H
Sbjct: 114 QQDQPVPHGTQCLAMGWGRVGAHDPPAQVLQELNVTVVT-------FFCRPHN------- 159
Query: 228 LCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGI-KCAAPYLPGVYMRTTYYKP 286
+C + C GDSGGPL+ DG ++ G S I CA P + R Y
Sbjct: 160 ICTFVPRRKAGICFGDSGGPLIC---DG--IIQGIDSFVIWGCATRLFPDFFTRVALYVD 214
Query: 287 WLQT 290
W+++
Sbjct: 215 WIRS 218
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 48.5 bits (114), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 64/166 (38%), Gaps = 31/166 (18%)
Query: 133 IVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVS-GWGRLKYGG 191
I YD NDI +L+L ++++ +P V ++ GWG L
Sbjct: 75 IFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNR 134
Query: 192 GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIE 251
G+ SVLQE+ V V+ ++C+ S +C Q C GDSG PL+
Sbjct: 135 GIASVLQELNVTVVT-SLCRR-------------SNVCTLVRGRQAGVCFGDSGSPLVCN 180
Query: 252 REDGHWVLAGTVSHGIK------CAAPYLPGVYMRTTYYKPWLQTI 291
+ HGI CA+ P + + W+ +I
Sbjct: 181 ----------GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSI 216
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 64/166 (38%), Gaps = 31/166 (18%)
Query: 133 IVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVS-GWGRLKYGG 191
I YD NDI +L+L ++++ +P V ++ GWG L
Sbjct: 75 IFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNR 134
Query: 192 GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIE 251
G+ SVLQE+ V V+ ++C+ S +C Q C GDSG PL+
Sbjct: 135 GIASVLQELNVTVVT-SLCRR-------------SNVCTLVRGRQAGVCFGDSGSPLVCN 180
Query: 252 REDGHWVLAGTVSHGIK------CAAPYLPGVYMRTTYYKPWLQTI 291
+ HGI CA+ P + + W+ +I
Sbjct: 181 ----------GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSI 216
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 48.1 bits (113), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 24/172 (13%)
Query: 123 RSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHI-----VPICMPKDDDDFTGR 177
+ S +++ + R Y T +N+ A++E E PI D +P + + D +
Sbjct: 63 KGTSVMAKKIYIVR-YHPLTMQNNYAVIETEMPIKLDDKTTKKIELPSLLYDPEPDTS-- 119
Query: 178 VATVSGWGR-----LKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGY 232
VSGWG L+Y G L E V++ C+E ++ K I + CAG
Sbjct: 120 -VLVSGWGSTNFKSLEYSGD----LMEANFTVVDRKSCEEQYKQIEADKYIYDGVFCAGG 174
Query: 233 ANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAAPYLPGVYMRTTYY 284
+ GD+G P + ++G L G S+ I P V++R YY
Sbjct: 175 EYDETYIGYGDAGDPAV---QNG--TLVGVASY-ISSMPSEFPSVFLRVGYY 220
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 48.1 bits (113), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 40/161 (24%), Positives = 63/161 (39%), Gaps = 31/161 (19%)
Query: 138 YDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVS-GWGRLKYGGGVPSV 196
YD NDI +L+L ++++ +P V ++ GWG L G+ SV
Sbjct: 80 YDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASV 139
Query: 197 LQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGH 256
LQE+ V V+ ++C+ S +C Q C GDSG PL+
Sbjct: 140 LQELNVTVVT-SLCRR-------------SNVCTLVRGRQAGVCFGDSGSPLVCN----- 180
Query: 257 WVLAGTVSHGIK------CAAPYLPGVYMRTTYYKPWLQTI 291
+ HGI CA+ P + + W+ +I
Sbjct: 181 -----GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSI 216
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 47.8 bits (112), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 40/161 (24%), Positives = 63/161 (39%), Gaps = 31/161 (19%)
Query: 138 YDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVS-GWGRLKYGGGVPSV 196
YD NDI +L+L ++++ +P V ++ GWG L G+ SV
Sbjct: 80 YDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASV 139
Query: 197 LQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIEREDGH 256
LQE+ V V+ ++C+ S +C Q C GDSG PL+
Sbjct: 140 LQELNVTVVT-SLCRR-------------SNVCTLVRGRQAGVCFGDSGSPLVCN----- 180
Query: 257 WVLAGTVSHGIK------CAAPYLPGVYMRTTYYKPWLQTI 291
+ HGI CA+ P + + W+ +I
Sbjct: 181 -----GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSI 216
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/136 (25%), Positives = 60/136 (44%), Gaps = 14/136 (10%)
Query: 93 FTINLSKIGFLANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLEL 152
F + +K L + V ++ + ++ + + V VH +YDA END++LLEL
Sbjct: 129 FVLTTAKCSLLHRNITVKTYFNRT----SQDPLMIKITHVHVHMRYDADAGENDLSLLEL 184
Query: 153 ETPIAYDSHIVPICMPKDDDDFTGRV------ATVSGWGRLKYGGGVPSVLQEVQVPVIE 206
E PI +P+C P + DF + +SGW R G + + L V ++E
Sbjct: 185 EWPIQCPGAGLPVCTP--EKDFAEHLLIPRTRGLLSGWAR--NGTDLGNSLTTRPVTLVE 240
Query: 207 NNVCQEMFQTAGHAKT 222
C ++ +T
Sbjct: 241 GEECGQVLNVTVTTRT 256
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/136 (25%), Positives = 60/136 (44%), Gaps = 14/136 (10%)
Query: 93 FTINLSKIGFLANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLEL 152
F + +K L + V ++ + ++ + + V VH +YDA END++LLEL
Sbjct: 88 FVLTTAKCSLLHRNITVKTYFNRT----SQDPLMIKITHVHVHMRYDADAGENDLSLLEL 143
Query: 153 ETPIAYDSHIVPICMPKDDDDFTGRV------ATVSGWGRLKYGGGVPSVLQEVQVPVIE 206
E PI +P+C P + DF + +SGW R G + + L V ++E
Sbjct: 144 EWPIQCPGAGLPVCTP--EKDFAEHLLIPRTRGLLSGWAR--NGTDLGNSLTTRPVTLVE 199
Query: 207 NNVCQEMFQTAGHAKT 222
C ++ +T
Sbjct: 200 GEECGQVLNVTVTTRT 215
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 63/166 (37%), Gaps = 31/166 (18%)
Query: 133 IVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVS-GWGRLKYGG 191
I YD NDI +L+L ++++ +P V ++ GWG L
Sbjct: 75 IFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNR 134
Query: 192 GVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIE 251
G+ SVLQE+ V V+ ++C+ S +C Q C GD G PL+
Sbjct: 135 GIASVLQELNVTVVT-SLCRR-------------SNVCTLVRGRQAGVCFGDXGSPLVCN 180
Query: 252 REDGHWVLAGTVSHGIK------CAAPYLPGVYMRTTYYKPWLQTI 291
+ HGI CA+ P + + W+ +I
Sbjct: 181 ----------GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSI 216
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 45.4 bits (106), Expect = 4e-05, Method: Composition-based stats.
Identities = 20/65 (30%), Positives = 38/65 (58%), Gaps = 5/65 (7%)
Query: 129 VRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT----GRVATVSG 183
+ ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + + G V+G
Sbjct: 8 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTG 67
Query: 184 WGRLK 188
WG LK
Sbjct: 68 WGNLK 72
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 44.3 bits (103), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 39/79 (49%), Gaps = 3/79 (3%)
Query: 110 FGEYDISGELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPK 169
GE++I LE N ++I H ++ T +NDI L++L +P +S + + +P+
Sbjct: 50 LGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR 107
Query: 170 DDDDFTGRVATVSGWGRLK 188
G +SGWG K
Sbjct: 108 SCAA-AGTECLISGWGNTK 125
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 44.3 bits (103), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 23/74 (31%), Positives = 43/74 (58%), Gaps = 7/74 (9%)
Query: 122 KRSISK--NVRRVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDDDFT--- 175
+R+I K + ++ +H +Y+ + DIAL++L+ P+A+ +I P+C+P + +
Sbjct: 72 ERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQ 131
Query: 176 -GRVATVSGWGRLK 188
G V+GWG LK
Sbjct: 132 AGYKGRVTGWGNLK 145
>pdb|1EPT|B Chain B, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 82
Score = 42.7 bits (99), Expect = 3e-04, Method: Composition-based stats.
Identities = 18/61 (29%), Positives = 32/61 (52%), Gaps = 1/61 (1%)
Query: 128 NVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRL 187
N ++I H ++ T +NDI L++L +P +S + + +P+ G +SGWG
Sbjct: 23 NAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAA-AGTECLISGWGNT 81
Query: 188 K 188
K
Sbjct: 82 K 82
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 40/189 (21%), Positives = 74/189 (39%), Gaps = 32/189 (16%)
Query: 109 VFGEYDISG-ELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICM 167
V G YD+ E +++++ S + + YD ND+ LL+L+ S + + +
Sbjct: 54 VLGAYDLRRRERQSRQTFSISS---MSENGYDPQQNLNDLMLLQLDREANLTSSVTILPL 110
Query: 168 PKDDDDF-TGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINS 226
P + G V+GWG + GG + + V V V + C+ +
Sbjct: 111 PLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP-------------N 157
Query: 227 FLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAA----PYLPGVYMRTT 282
+C G + C GD G PL+ E ++HG+ + P + R
Sbjct: 158 NVCTGVLTRRGGICNGDQGTPLVCE----------GLAHGVASFSLGPCGRGPDFFTRVA 207
Query: 283 YYKPWLQTI 291
++ W+ +
Sbjct: 208 LFRDWIDGV 216
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 40/189 (21%), Positives = 74/189 (39%), Gaps = 32/189 (16%)
Query: 109 VFGEYDISG-ELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICM 167
V G YD+ E +++++ S + + YD ND+ LL+L+ S + + +
Sbjct: 54 VLGAYDLRRRERQSRQTFSISS---MSENGYDPQQNLNDLMLLQLDREANLTSSVTILPL 110
Query: 168 PKDDDDF-TGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINS 226
P + G V+GWG + GG + + V V V + C+ +
Sbjct: 111 PLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP-------------N 157
Query: 227 FLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAA----PYLPGVYMRTT 282
+C G + C GD G PL+ E ++HG+ + P + R
Sbjct: 158 NVCTGVLTRRGGICNGDGGTPLVCE----------GLAHGVASFSLGPCGRGPDFFTRVA 207
Query: 283 YYKPWLQTI 291
++ W+ +
Sbjct: 208 LFRDWIDGV 216
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 41.2 bits (95), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 40/189 (21%), Positives = 74/189 (39%), Gaps = 32/189 (16%)
Query: 109 VFGEYDISG-ELEAKRSISKNVRRVIVHRQYDAATFENDIALLELETPIAYDSHIVPICM 167
V G YD+ E +++++ S + + YD ND+ LL+L+ S + + +
Sbjct: 54 VLGAYDLRRRERQSRQTFSISS---MSENGYDPQQNLNDLMLLQLDREANLTSSVTILPL 110
Query: 168 PKDDDDF-TGRVATVSGWGRLKYGGGVPSVLQEVQVPVIENNVCQEMFQTAGHAKTIINS 226
P + G V+GWG + GG + + V V V + C+ +
Sbjct: 111 PLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP-------------N 157
Query: 227 FLCAGYANGQRDSCEGDSGGPLMIEREDGHWVLAGTVSHGIKCAA----PYLPGVYMRTT 282
+C G + C GD G PL+ E ++HG+ + P + R
Sbjct: 158 NVCTGVLTRRGGICNGDGGTPLVCE----------GLAHGVASFSLGPCGRGPDFFTRVA 207
Query: 283 YYKPWLQTI 291
++ W+ +
Sbjct: 208 LFRDWIDGV 216
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/156 (25%), Positives = 63/156 (40%), Gaps = 15/156 (9%)
Query: 136 RQYDAATFENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLK-YGGGVP 194
R YD +D+ LL L P + + +P + G SGWG + +
Sbjct: 88 RPYD--DISHDLMLLRLAQPARITDAVKILDLPTQEPKL-GSTCYTSGWGLISTFTNRGS 144
Query: 195 SVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIERED 254
LQ V++ + N C + + + LCA + + C GDSGG L+ D
Sbjct: 145 GTLQCVELRLQSNEKCARAY-----PEKMTEFVLCATHRDDSGSICLGDSGGALIC---D 196
Query: 255 GHWVLAGTVSHGI-KCAAPYLPGVYMRTTYYKPWLQ 289
G V G S G +CA V+ + +K W++
Sbjct: 197 G--VFQGITSWGYSECADFNDNFVFTKVMPHKKWIK 230
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 38.1 bits (87), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 21/63 (33%), Positives = 33/63 (52%), Gaps = 11/63 (17%)
Query: 131 RVIVHRQYD-AATFENDIALLELETPIAYDSHIVPICMPKDDD-------DFTGRVATVS 182
++ +H +Y+ + DIALL+L+ PI +I P+C+P F GR V+
Sbjct: 83 KIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGR---VT 139
Query: 183 GWG 185
GWG
Sbjct: 140 GWG 142
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 34.7 bits (78), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 67/158 (42%), Gaps = 18/158 (11%)
Query: 138 YDAATFENDIALLELETPIAYDS-HIVPICMPKDDDDF---TGRVATVSGWGRLKYGGGV 193
Y T ENDIA+LEL P+ D P +P D +F TG VSG+G +
Sbjct: 81 YRQETMENDIAILELSRPLKLDGLKSKPAKLP--DIEFRPKTGSDVLVSGYGDGQTMDPK 138
Query: 194 PSVLQEVQVPVIENNVCQEMFQTAGHAKTIINSFLCAGYANGQRDSCEGDSGGPLMIERE 253
L+ Q+ V++ + C+ + G + F CA +S GD+G P + +
Sbjct: 139 DHDLKSAQLTVVDLDECRTKY---GPIFLSLQVF-CAQKVGVSLES--GDAGDPTVQQD- 191
Query: 254 DGHWVLAGTVSHGIKCAAPYLPGVYMRTTYYKPWLQTI 291
L G ++ K P V+ + Y W+Q I
Sbjct: 192 ----TLVGVAAYFPK-RPEGAPEVFTKVGSYVSWIQDI 224
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 33.9 bits (76), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 34/150 (22%), Positives = 63/150 (42%), Gaps = 26/150 (17%)
Query: 143 FENDIALLELETPIAYDSHIVPICMPKDDDDFTGRVATVSGWGRLKYGGGVPS------V 196
++ D+AL++L+ + Y I PIC+P + + + + +P+
Sbjct: 107 YDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALF 166
Query: 197 LQEVQVPVIENNV----------CQEMFQTA-GHAKT------IINSFLCAGYANGQRD- 238
+ E + + V C+ Q A G+ K + FLC G + D
Sbjct: 167 VSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADP 226
Query: 239 -SCEGDSGGPLMIEREDGHWVLAGTVSHGI 267
+C GDSGGPL++ + ++ G +S G+
Sbjct: 227 NTCRGDSGGPLIVHKR-SRFIQVGVISWGV 255
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 33.9 bits (76), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 28/50 (56%), Gaps = 3/50 (6%)
Query: 220 AKTIINSFLCAGYANGQRD--SCEGDSGGPLMIEREDGHWVLAGTVSHGI 267
++ + FLC G + D +C GDSGGPL++ + ++ G +S G+
Sbjct: 414 SEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 462
Score = 29.3 bits (64), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 10/26 (38%), Positives = 18/26 (69%)
Query: 143 FENDIALLELETPIAYDSHIVPICMP 168
++ D+AL++L+ + Y I PIC+P
Sbjct: 314 YDYDVALIKLKNKLKYGQTIRPICLP 339
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 33.9 bits (76), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 33/146 (22%), Positives = 61/146 (41%), Gaps = 23/146 (15%)
Query: 143 FENDIALLELETPIAYDSHIVPICMP------------------KDDDDFTGRVATVSGW 184
+ +DIALL+L + +H PIC+P +++ + + + +
Sbjct: 315 YGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHENELLNKQSVPAHF 374
Query: 185 GRLKYGGGVPSVLQEVQVPVIENNVCQE--MFQTAGHAKTII-NSFLCAGYANGQRDSCE 241
L ++ V+ V QE MF + ++ + FLC+G + C+
Sbjct: 375 VALNGSKLNINLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSGTQEDE-SPCK 433
Query: 242 GDSGGPLMIEREDGHWVLAGTVSHGI 267
G+SGG + +ER + G VS G+
Sbjct: 434 GESGGAVFLERR-FRFFQVGLVSWGL 458
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 33.9 bits (76), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 33/146 (22%), Positives = 61/146 (41%), Gaps = 23/146 (15%)
Query: 143 FENDIALLELETPIAYDSHIVPICMP------------------KDDDDFTGRVATVSGW 184
+ +DIALL+L + +H PIC+P +++ + + + +
Sbjct: 323 YGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHENELLNKQSVPAHF 382
Query: 185 GRLKYGGGVPSVLQEVQVPVIENNVCQE--MFQTAGHAKTII-NSFLCAGYANGQRDSCE 241
L ++ V+ V QE MF + ++ + FLC+G + C+
Sbjct: 383 VALNGSKLNINLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSGTQEDE-SPCK 441
Query: 242 GDSGGPLMIEREDGHWVLAGTVSHGI 267
G+SGG + +ER + G VS G+
Sbjct: 442 GESGGAVFLERR-FRFFQVGLVSWGL 466
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 33.9 bits (76), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 28/50 (56%), Gaps = 3/50 (6%)
Query: 220 AKTIINSFLCAGYANGQRD--SCEGDSGGPLMIEREDGHWVLAGTVSHGI 267
++ + FLC G + D +C GDSGGPL++ + ++ G +S G+
Sbjct: 406 SEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 454
Score = 29.3 bits (64), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 10/26 (38%), Positives = 18/26 (69%)
Query: 143 FENDIALLELETPIAYDSHIVPICMP 168
++ D+AL++L+ + Y I PIC+P
Sbjct: 306 YDYDVALIKLKNKLKYGQTIRPICLP 331
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 33.1 bits (74), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 28/50 (56%), Gaps = 3/50 (6%)
Query: 220 AKTIINSFLCAGYANGQRD--SCEGDSGGPLMIEREDGHWVLAGTVSHGI 267
++ + FLC G + D +C GDSGGPL++ + ++ G +S G+
Sbjct: 639 SEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 687
Score = 29.6 bits (65), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 10/26 (38%), Positives = 18/26 (69%)
Query: 143 FENDIALLELETPIAYDSHIVPICMP 168
++ D+AL++L+ + Y I PIC+P
Sbjct: 539 YDYDVALIKLKNKLKYGQTIRPICLP 564
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 33.1 bits (74), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 28/50 (56%), Gaps = 3/50 (6%)
Query: 220 AKTIINSFLCAGYANGQRD--SCEGDSGGPLMIEREDGHWVLAGTVSHGI 267
++ + FLC G + D +C GDSGGPL++ + ++ G +S G+
Sbjct: 658 SEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 706
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 33.1 bits (74), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 28/50 (56%), Gaps = 3/50 (6%)
Query: 220 AKTIINSFLCAGYANGQRD--SCEGDSGGPLMIEREDGHWVLAGTVSHGI 267
++ + FLC G + D +C GDSGGPL++ + ++ G +S G+
Sbjct: 648 SEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 696
>pdb|3MFH|A Chain A, Dna Polymerase Eta In Complex With Undamaged Dna
pdb|3MFI|A Chain A, Dna Polymerase Eta In Complex With A Cis-Syn Thymidine
Dimer
pdb|3OHA|A Chain A, Yeast Dna Polymerase Eta Inserting Dctp Opposite An 8oxog
Lesion
pdb|3OHB|A Chain A, Yeast Dna Polymerase Eta Extending From An 8-Oxog Lesion
Length = 520
Score = 29.6 bits (65), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 18/69 (26%), Positives = 35/69 (50%), Gaps = 3/69 (4%)
Query: 71 SRHTLYTLQFPQQDSMMTNFDMFTINLSKIGFLANLVAVFGEYDISGELEAKRSISKNVR 130
SR L ++ + D ++L +I F N++ EY+++G+L+ K ++S N+R
Sbjct: 142 SRKALAIFKWACDLVERASIDEVFLDLGRICF--NMLMFDNEYELTGDLKLKDALS-NIR 198
Query: 131 RVIVHRQYD 139
+ YD
Sbjct: 199 EAFIGGNYD 207
>pdb|2WTF|A Chain A, Dna Polymerase Eta In Complex With The
Cis-Diammineplatinum (Ii) 1,3-Gtg Intrastrand Cross-Link
pdb|2WTF|B Chain B, Dna Polymerase Eta In Complex With The
Cis-Diammineplatinum (Ii) 1,3-Gtg Intrastrand Cross-Link
pdb|2XGP|A Chain A, Yeast Dna Polymerase Eta In Complex With C8-2-
Acetylaminofluorene Containing Dna
pdb|2XGP|B Chain B, Yeast Dna Polymerase Eta In Complex With C8-2-
Acetylaminofluorene Containing Dna
pdb|2XGQ|A Chain A, Structure Of Yeast Dna Polymerase Eta In Complex With
C8-N- Acetyl-2-Aminoanthracene Containing Dna
pdb|2XGQ|B Chain B, Structure Of Yeast Dna Polymerase Eta In Complex With
C8-N- Acetyl-2-Aminoanthracene Containing Dna
Length = 536
Score = 28.9 bits (63), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 15/52 (28%), Positives = 30/52 (57%), Gaps = 3/52 (5%)
Query: 88 TNFDMFTINLSKIGFLANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYD 139
+ D ++L +I F N++ EY+++G+L+ K ++S N+R + YD
Sbjct: 175 ASIDEVFLDLGRICF--NMLMFDNEYELTGDLKLKDALS-NIREAFIGGNYD 223
>pdb|2R8J|A Chain A, Structure Of The Eukaryotic Dna Polymerase Eta In Complex
With 1,2- D(gpg)-cisplatin Containing Dna
pdb|2R8J|B Chain B, Structure Of The Eukaryotic Dna Polymerase Eta In Complex
With 1,2- D(gpg)-cisplatin Containing Dna
pdb|2R8K|A Chain A, Structure Of The Eukaryotic Dna Polymerase Eta In Complex
With 1,2- D(gpg)-cisplatin Containing Dna
pdb|2R8K|B Chain B, Structure Of The Eukaryotic Dna Polymerase Eta In Complex
With 1,2- D(gpg)-cisplatin Containing Dna
Length = 554
Score = 28.9 bits (63), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 15/51 (29%), Positives = 30/51 (58%), Gaps = 3/51 (5%)
Query: 89 NFDMFTINLSKIGFLANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYD 139
+ D ++L +I F N++ EY+++G+L+ K ++S N+R + YD
Sbjct: 176 SIDEVFLDLGRICF--NMLMFDNEYELTGDLKLKDALS-NIREAFIGGNYD 223
>pdb|1JIH|A Chain A, Yeast Dna Polymerase Eta
pdb|1JIH|B Chain B, Yeast Dna Polymerase Eta
Length = 513
Score = 28.5 bits (62), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 15/52 (28%), Positives = 30/52 (57%), Gaps = 3/52 (5%)
Query: 88 TNFDMFTINLSKIGFLANLVAVFGEYDISGELEAKRSISKNVRRVIVHRQYD 139
+ D ++L +I F N++ EY+++G+L+ K ++S N+R + YD
Sbjct: 152 ASIDEVFLDLGRICF--NMLMFDNEYELTGDLKLKDALS-NIREAFIGGNYD 200
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.137 0.418
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 8,289,754
Number of Sequences: 62578
Number of extensions: 338569
Number of successful extensions: 1774
Number of sequences better than 100.0: 356
Number of HSP's better than 100.0 without gapping: 335
Number of HSP's successfully gapped in prelim test: 21
Number of HSP's that attempted gapping in prelim test: 679
Number of HSP's gapped (non-prelim): 364
length of query: 295
length of database: 14,973,337
effective HSP length: 98
effective length of query: 197
effective length of database: 8,840,693
effective search space: 1741616521
effective search space used: 1741616521
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 51 (24.3 bits)